Sources: 1BitterDB, 4ClinicalTrials, 7Cochrane Library, 10DGIdb, 14DrugBank, 29HMDB, 33IUPHAR, 46NDF-RT, 50Novoseek, 56PharmGKB, 68UMLSSee all MalaCards sources |
Drugs for 3-Hydroxyacyl-Coa Dehydrogenase Deficiency (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB): (show top 50)
(show all 910)
| id | | Name | Status | Phase | Clinical Trials | Cas Number | PubChem Id |
|---|
| 1 | | Acetazolamide | approved, vet_approved | Phase 4 | 80 | 59-66-5 | 1986 | 1424-27-7 (mono-hydrochloride salt) 1yda 1ydb 1ydd 1zsb 2-acetylamino-1,3,4-thiadiazole-5-sulfonamide 2h4n 3czv 4-Diamox 5-acetamido-1,3,4-thiadiazole-2-sulfonamide 5-acetylamino-1,3,4-thiadiazole-2-sulfonamide 5661-25-6 59-66-5 8017-69-4 A 6011 A6011_SIAL A6011_SIGMA AB00051906 AC-12779 AC1L1CO5 AI3-52458 AKOS000715163 Acetadiazol Acetamidothiadiazolesulfonamide Acetamox Acetazolam Acetazolamid Acetazolamida Acetazolamida [INN-Spanish] Acetazolamide (AAZ) Acetazolamide (JP15/USP/INN) Acetazolamide Apotex Brand Acetazolamide Chiesi Brand Acetazolamide Dioptic Brand Acetazolamide Grin Brand Acetazolamide ICN Brand Acetazolamide Jumer Brand Acetazolamide Llorens Brand Acetazolamide Medphano Brand Acetazolamide Novopharm Brand Acetazolamide Orion Brand Acetazolamide Sodium Acetazolamide Sodium, (Sterile) Acetazolamide Wassermann Brand Acetazolamide [INN:BAN:JAN] Acetazolamide, Monosodium Salt Acetazolamidum Acetazolamidum [INN-Latin] Acetazolamine Acetazoleamide Acetozalamide Acétazolamide Ak Zol Ak-Zol AkZol Apo Acetazolamide Apo-Acetazolamide ApoAcetazolamide Apotex Brand of Acetazolamide Atenezol BAS 01585728 BIDD:GT0643 BPBio1_000007 BSPBio_000005 BSPBio_001788 C06805 C4H6N4O3S2 CAS-59-66-5 CCRIS 5811 CHEBI:27690 CHEMBL20 CID1986 CPD0-1626 CPD000058394 Carbonic Anhydrase Inhibitor 6063 Carbonic Anhydrase Inhibitor No. 6063 Carbonic anhydrase inhibitor 6063 Chiesi Brand of Acetazolamide Ciba Vision Brand of Acetazolamide Cidamex D000086 D00218 DB00819 Dazamide Defiltran Dehydratin Diacarb Diakarb Diamox Diamox (TN) Diamox Sequels Didoc Diluran | Dioptic Brand of Acetazolamide Diuramid Diuramide Diureticum-Holzinger Diureticum-holzinger Diuriwas Diutazol DivK1c_000017 Donmox Duiramid EINECS 200-440-5 EU-0100039 Edemox Eumicton Fonurit Glauconox Glaumox Glaupax Glupax Grin Brand of Acetazolamide HMS1568A07 HMS1920A05 HMS2091G05 HMS500A19 HSDB 3002 Huma Zolamide Huma-Zolamide HumaZolamide I09-0425 ICN Brand of Acetazolamide IDI1_000017 Jumer Brand of Acetazolamide KBio1_000017 KBio2_000358 KBio2_002926 KBio2_005494 KBio3_001288 KBioGR_000558 KBioSS_000358 LS-10227 Llorens Brand of Acetazolamide Lopac-A-6011 Lopac0_000039 MLS000028435 MLS001148438 Medphano Brand of Acetazolamide MolPort-001-783-578 Monosodium Salt Acetazolamide N-[5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide N-[5-(aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide NCGC00015074-01 NCGC00015074-02 NCGC00015074-03 NCGC00015074-06 NCGC00015074-11 NCGC00023455-03 NCGC00023455-04 NCGC00023455-05 NCGC00023455-06 NCGC00023455-07 NINDS_000017 NSC 145177 NSC145177 Natrionex Nephramid Nephramide Novopharm Brand of Acetazolamide Orion Brand of Acetazolamide Phonurit Prestwick0_000003 Prestwick1_000003 Prestwick2_000003 Prestwick3_000003 Prestwick_4 SAM002554883 SBB056640 SK-acetazolamide SMR000058394 SPBio_000004 SPBio_001926 SPECTRUM1500102 Sk-Acetazolamide Spectrum2_000082 Spectrum3_000284 Spectrum4_000139 Spectrum5_000738 Spectrum_000018 Storz Brand of Acetazolamide Preparation Storzolamide UNII-O3FX965V0I Vetamox WLN: T5NN DSJ CSZW EMV1 Wassermann Brand of Acetazolamide Wyeth Brand of Acetazolamide Preparation acetazolamide |
| | 2 | | Sevelamer | approved | Phase 4, Phase 3 | 74 | 52757-95-6, 152751-57-0 | 3085017 | | Sevelamero Sevelamerum Sévélamer |
| | 3 | | Bezafibrate | approved | Phase 4, Phase 3, Phase 2 | 14 | 41859-67-0 | 39042 | 2-(4-{2-[(4-chlorobenzoyl)amino]ethyl}phenoxy)-2-methylpropanoic acid 2-(P-(2-(P-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid 2-(p-(2-(p-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid 2-[4-(2-[4-Chlorobenzamido]ethyl)- phenoxy]-2-methylpropanoic acid 2-[4-[2-(4-Chlorobenzamido)ethyl]phenoxy]-2-methylpropanoic acid 2-[4-[2-(4-Chlorobenzamido)ethyl]phenoxy]isobutyric Acid 2-[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenoxy]-2-methylpropanoic acid 41859-67-0 AB00052265 AB1004588 AC-6817 AC1L20XS AC1Q5E4V AKOS005107743 Azufibrat Azupharma Brand of Bezafibrate B3346 B7273_SIGMA BF-759 BM 15.075 BM 15075 BM-15.075 BM-15075 BM15.075 BPBio1_000589 BRD-K46018455-001-06-0 BRN 4267656 BSPBio_000535 BSPBio_001314 BSPBio_003119 Bayer Brand of Bezafibrate Befibrat Befizal Berlin Chemie Brand of Bezafibrate Berlin-Chemie Brand of Bezafibrate Betapharm Brand of Bezafibrate Beza Lande Beza Puren Beza-Lande Beza-Puren BezaLande BezaPuren Bezabeta Bezacur Bezafibrat Bezafibrat PB Bezafibrate (JP15/USAN/INN) Bezafibrate Azupharma Brand Bezafibrate Bayer Brand Bezafibrate Berlin-Chemie Brand Bezafibrate Betapharm Brand Bezafibrate Cryopharma Brand Bezafibrate Elfar Brand Bezafibrate Hennig Brand Bezafibrate Hexal Brand Bezafibrate Isis Brand Bezafibrate Lakeside Brand Bezafibrate Merckle Brand Bezafibrate Roche Brand Bezafibrate Synthelabo Brand Bezafibrate TAD Brand Bezafibrate Teva Brand Bezafibrate [USAN:BAN:INN:JAN] Bezafibrato Bezafibrato [INN-Spanish] Bezafibrato [Spanish] Bezafibrato [inn-spanish] Bezafibratum Bezafibratum [INN-Latin] Bezafibratum [inn-latin] Bezafisal Bezalip Bezalip Retard Bezamerck Bezatol Bezatol SR Bezatol SR (TN) Bezatol sr (tn) Bio2_000034 Bio2_000514 Boehringer Mannheim Brand of Bezafibrate C19H20ClNO4 CAS-41859-67-0 CCRIS 9085 CHEBI:47612 | CHEMBL264374 CID39042 Cedur Cryopharma Brand of Bezafibrate D001629 D01366 DB01393 DB08380 Difaterol DivK1c_000092 EINECS 255-567-9 Elfar Brand of Bezafibrate Eulitop HMS1361B16 HMS1569K17 HMS1791B16 HMS1921H16 HMS1989B16 HMS2089F04 HMS2092B12 HMS500E14 Hennig Brand of Bezafibrate Hexal Brand of Bezafibrate I06-1311 IDI1_000092 IDI1_033784 Isis Brand of Bezafibrate KBio1_000092 KBio2_000034 KBio2_001923 KBio2_002602 KBio2_004491 KBio2_005170 KBio2_007059 KBio3_000067 KBio3_000068 KBio3_002619 KBioGR_000034 KBioGR_000669 KBioSS_000034 KBioSS_001923 LO 44 LS-124535 Lakeside Brand of Bezafibrate Lipox MLS000028533 MLS001148205 Merckle Brand of Bezafibrate MolPort-001-738-424 NCGC00016850-01 NCGC00016850-02 NCGC00016850-11 NCGC00023317-03 NCGC00023317-04 NCGC00023317-05 NCGC00023317-06 NCGC00023317-07 NCGC00023317-08 NINDS_000092 PB, Bezafibrat Prestwick0_000378 Prestwick1_000378 Prestwick2_000378 Prestwick3_000378 Prestwick_724 Reducterol Regadrin B Roche Brand of Bezafibrate SMR000058298 SPBio_000824 SPBio_002456 SPECTRUM1502046 ST51014927 Sklerofibrat Solibay Spectrum2_000922 Spectrum3_001500 Spectrum4_000325 Spectrum5_001079 Spectrum5_001967 Spectrum_001443 Synthelabo Brand of Bezafibrate TAD Brand of Bezafibrate Teva Brand of Bezafibrate a-[4-(4-chlorobenzoylaminoethyl)phenoxy]isobutyric acid bezafibrate durabezur |
| | 4 | | Calcium carbonate | approved | Phase 4, Phase 3, Phase 2 | 215 | 471-34-1 | | CaCO3 Calcium carbonate Calcium carbonate (1:1) Calciumcarbonat Carbonate de calcium | Carbonato de calcio Carbonic acid calcium salt (1:1) E 170 Kalziumkarbonat Kohlensaurer kalk Precipitated calcium carbonate | |
| | 5 | | Calcium acetate | approved | Phase 4, Phase 3, Phase 1 | 20 | 62-54-4 | | Acetate OF lime Brown acetate of lime Ca(oac)2 | Gray acetate of lime Lime acetate Lime pyrolignite calcium ethanoate calcium(II) acetate |
| | 6 | | Insulin-glulisine | approved | Phase 4, Phase 2, Phase 1 | 106 | 207748-29-6 | | Insulin Glulisine (recombinant DNA origin) Insulin glulisine recombinant | |
| | 7 | | Alendronate | approved | Phase 4, Phase 2 | 162 | 121268-17-5, 66376-36-1 | 2088 | (4-Amino-1-hydroxybutylidene)bisphosphonic acid (4-Amino-1-hydroxybutylidene)diphosphonic acid (4-amino-1-hydroxy-1-phosphonobutyl)phosphonic acid (4-amino-1-hydroxybutane-1,1-diyl)bis(phosphonic acid) (4-amino-1-hydroxybutylidene)bisphosphonic acid 121268-17-5 (mono-hydrochloride salt, trihydrate) 1yhm 4-Amino-1-hydroxybutane-1,1-diphosphonate 4-Amino-1-hydroxybutane-1,1-diphosphonic Acid 4-Amino-1-hydroxybutylidene-1,1-bis(phosphonic acid) 4-Amino-1-hydroxybutylidene-1,1-bisphosphonate 4-amino-1-hydroxybutane-1,1-diphosphonic acid 66376-36-1 ABDP AC1L1CW3 AKOS001015793 ALENDRONATE SODIUM ALENDRONIC ACID Acide Alendronique Acide Alendronique [INN-French] Acide alendronique Acide alendronique [INN-French] Acido Alendronico Acido Alendronico [INN-Spanish] Acido alendronico Acido alendronico [INN-Spanish] Acidum Alendronicum Acidum Alendronicum [INN-Latin] Acidum alendronicum Acidum alendronicum [INN-Latin] Adronat | Alendronate Alendronate Sodium Alendronate sodium hydrate Alendronic acid Alendronic acid (INN) Alendronic acid [INN:BAN] Alendros Arendal BIDD:GT0180 C07752 CHEBI:2567 CHEMBL870 CID2088 D07119 DB00630 Fosamax Fosamax Plus D HSCI1_000337 LS-106421 MK 217 MK-217 MolPort-000-421-410 NCGC00096054-01 NCGC00096054-03 NCGC00096054-04 Onclast Oprea1_422906 Phosphonic acid, (4-amino-1-hydroxybutylidene)bis SPECTRUM1505166 ST50036159 UNII-X1J18R4W8P alendronate bisphosphonate, 65 |
| | 8 | | Repaglinide | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 51 | 135062-02-1 | 65981 | (+)-2-Ethoxy-alpha-(((S)-alpha-isobutyl-o-piperidinobenzyl)carbamoyl)-p-toluic acid (S)-(+)-2-Ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid (S)-2-Ethoxy-4-(2-((methyl-1-(2-(1-piperidinyl)phenyl)butyl)amino)-2-oxoethyl)-benzoic acid (S)-2-ethoxy-4-(2-((3-methyl-1-(2-(1-piperidinyl)-phenyl)butyl)amino)-2-oxoethyl)-benzoic acid 111GE012 135062-02-1 2-ethoxy-4-(2-((3-methyl-1-(2-(1-piperidinyl)phenyl)butyl)amino)-2-oxoethyl)benzoic acid 2-ethoxy-4-(2-{[(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino}-2-oxoethyl)benzoic acid 2-ethoxy-4-[2-({(1S)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl}amino)-2-oxoethyl]benzoic acid 2-ethoxy-4-[2-[[(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino]-2-oxoethyl]benzoic acid 2-ethoxy-N-(alpha-(2-methyl-1-propyl)-2-piperidinobenzyl)-4-carbamoylmethylbenzoic acid AB00514019 AC-726 AC1L24D5 AC1Q5TZW AG-EE 388 AG-EE 388 ZW AG-EE 623 ZW AG-EE-388 AG-EE-623 ZW AGEE-623ZW Actulin BIDD:GT0338 BPBio1_001070 BRD-K82846253-001-03-0 BSPBio_000972 Bio-0087 C072379 C07670 C27H36N2O4 CAS-135062-02-1 CHEBI:348669 CHEMBL1272 CID65981 CPD000466305 D00594 DB00912 Glaxo Wellcome brand of replaginide | GlucoNorm HMS1571A14 HMS2051N08 HMS2094C07 LS-38509 MLS000759407 MLS001076684 MolPort-003-850-140 NCGC00016978-01 NCGC00016978-02 NN-623 Novo Nordisk brand 2 of repaglinide Novo Nordisk brand of repaglinide NovoNorm Prandin Prandin (TN) Prandin, GlucoNorm, NovoNorm, Repaglinide Prestwick0_001046 Prestwick1_001046 Prestwick2_001046 Prestwick3_001046 R9028_SIGMA Repaglinida Repaglinida [INN-Spanish] Repaglinide Repaglinide (JAN/USP/INN) Repaglinide [USAN] Repaglinidum Repaglinidum [INN-Latin] S1426_Selleck SAM001246546 SMP-508 SMR000466305 SPBio_002906 STK629501 Surepost UNII-668Z8C33LU repa-glinide repaglinide repaglinide, (+-)-isomer |
| | 9 | | Pramlintide | approved, investigational | Phase 4, Phase 3, Phase 1, Phase 2 | 43 | 151126-32-8 | | 151126-32-8 187887-46-3 196078-30-5 AC 0137 AC0137 L-Tyrosinamide, L-lysyl-L-cysteinyl-L-asparaginyl-L-threonyl-L-alanyl-L-threonyl-L-cysteinyl-L-alanyl-L-threonyl-L-glutaminyl-L-arginyl-L-leucyl-L-alanyl-L-asparaginyl-L-phenylalanyl-L-leucyl-L-valyl-L-histidyl-L-seryl-L-seryl-L-asparaginyl-L-asparaginyl-L-phenylalanylglycyl-L-prolyl-L-isoleucyl-L-leucyl-L-prolyl-L-prolyl-L-threonyl-L-asparaginyl-L-valylglycyl-L-seryl-L-asparaginyl-L-threonyl-, cyclic (2-7)-disulfide LS-181996 LS-188084 | Pramlintide Pramlintide [USAN] Pramlintide acetate Pramlintide acetate [USAN] Pramlintide acetate hydrate Symlin Triproamylin UNII-726I6TE06G UNII-D3FM8FA78T | |
| | 10 | | Cilostazol | approved | Phase 4 | 106 | 73963-72-1 | 2754 | 3,4-Dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone 3,4-dihydro-6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxyl)-3,4-dihydrocarobostyril 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-1H-quinolin-2-one 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-2(1H)-quinolinone 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydroquinolin-2(1H)-one 6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-3,4-dihydro-1H-quinolin-2-one 73963-72-1 89332-50-3 AC-4334 AC1L1EE2 BRD-K67017579-001-04-2 BRD-K67017579-001-05-9 BRD-K67017579-001-07-5 BRD-K67017579-001-13-3 BRN 3632107 BSPBio_002759 C 0737 C045645 C0737_SIGMA C20H27N5O2 CHEBI:31401 CHEMBL799 CID2754 CL23867 CPD000058428 Cilostazol (JP15/USAN/INN) Cilostazol [INN:JAN] Cilostazole Cilostazolum Cilostazolum [INN-Latin] D01896 DB01166 EU-0100218 HMS1922N15 HMS2093M14 KBio3_002259 KBioGR_001184 | LS-142693 Lopac-C-0737 Lopac0_000218 MLS000028470 MLS000758281 MLS000759507 MLS001076067 MLS002153891 MolPort-001-758-007 NCGC00015207-01 NCGC00015207-02 NCGC00015207-06 NCGC00015207-10 NCGC00022153-02 NCGC00022153-04 NCGC00022153-05 NCGC00022153-06 NCGC00022153-07 OPC 13013 OPC 21 OPC-13013 OPC-21 Otsuka brand of cilostazol Pletaal Pletal Pletal (TN) Pletal, Cilostazol S1294_Selleck SAM001246734 SAM001247085 SMR000058428 SPBio_001256 SPECTRUM1505230 Spectrum2_001118 Spectrum3_001170 Spectrum4_000772 Spectrum5_001762 TL8005113 Tocris-1692 UNII-N7Z035406B ZINC01552174 cilostazol |
| | 11 | | Octreotide | approved, investigational | Phase 4, Phase 2, Phase 1 | 223 | 83150-76-9 | 383414, 6400441 | (4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide 10-(4-Aminobutyl)-19-((2-amino-3-phenylpropanoyl)amino)-16-benzyl-7-(1-hydroxyethyl)-N-(2-hydroxy-1-(hydroxymethyl)propyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaa 10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-(1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide 10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide 79517-01-4 (acetate salt) 83150-76-9 AC1L1GVU AC1L8LCD AC1L9M4X C07306 C5H12O2.C4H10 CHEBI:427278 CHEBI:611465 CHEMBL1680 CID383414 CID448601 CID54374 D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-L-threoninol cyclic (2-7)-disulfide D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl)-L-cysteinamide cyclic (2-7)-disulfide D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl)-L-cysteinamide cyclic (2->7)-disulfide D00442 DRG-0115 HMS2090C09 HS-2020 | L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L- threonyl-N-(2-hydroxy-1-(hydroxymethyl)propyl)-, cyclic (2->7)-disulfide, (R-(R* L000453 LS-177735 LS-187135 Longastatin NCGC00181796-01 NCI60_025753 Octreotida Octreotida [Spanish] Octreotide Octreotide (USAN/INN) Octreotide Acetate Salt Octreotide [USAN:INN:BAN] Octreotide-LAR Octreotidum Octreotidum [Latin] Octrotide SAN 201-995 SM 201-995 SMS 201-995 SMS-201-995 Sandostatine Sandoz 201-995 UNII-RWM8CCW8GP nchembio.184-comp3 zacycloicosane-4-carboxamide acetate |
| | 12 | | Prednisolone | approved, vet_approved | Phase 4, Phase 2, Phase 1 | 1193 | 50-24-8 | 5755 | (11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione .DELTA.1-Cortisol .DELTA.1-Dehydrocortisol .DELTA.1-Dehydrohydrocortisone .DELTA.1-Hydrocortisone .delta.-Cortef .delta.-Stab 1,2-Dehydrohydrocortisone 1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione 1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol 1-Dehydrocortisol 1-Dehydrohydrocortisone 3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene 46656_FLUKA 46656_RIEDEL 50-24-8 58201-11-9 8056-11-9 AC-1773 AC1L1L2E Ak-Pred Ak-Tate Alphadrol Articulose-50 BPBio1_000164 BRD-K98039984-001-03-0 BRN 1354103 BSPBio_000148 Bio-0666 Bubbli-Pred C07369 CCRIS 980 CHEBI:8378 CHEMBL131 CID5755 CO-Hydeltra CPD000718761 Co-Hydeltra Codelcortone Cordrol Cortalone Cotogesic Cotolone D00472 D011239 DB00860 Decaprednil Decortin H Delcortol Delta F Delta(1)-dehydrohydrocortisone Delta-Cortef Delta-Cortef (TN) Delta-Ef-Cortelan Delta-Stab Delta-stab Deltacortenol Deltacortril Deltacortril Enteric Deltahydrocortisone Deltasolone Deltisilone Depo-Medrol Derpo PD Derpo Pd Dexa-Cortidelt Hostacortin H Dexa-Cortidelt hostacortin H Di Adreson F Di-Adreson F Di-Adreson-F Di-adreson F DiAdresonF Dicortol Donisolone Dydeltrone EINECS 200-021-7 Eazolin D Econopred Econopred Plus Erbacort Erbasona Estilsona Fernisolone Fernisolone P Fernisolone-P Flamasone HMS1568H10 HMS2090J05 HSDB 3385 Hostacortin H Hydeltra Hydeltra-Tba Hydeltrasol Hydeltrone Hydrodeltalone Hydrodeltisone Hydroretrocortin Hydroretrocortine I-Pred Inflamase Forte Inflamase Mild K 1557 Key-Pred Klismacort LMST02030179 LS-7669 Lentosone Lite Pred M-Predrol | MLS001304083 MLS002154250 MLS002207037 Medrol Medrol Acetate Metacortandralone Methylprednisolone Acetate Meti-Derm Meticortelone Metreton MolPort-002-507-147 NCGC00179649-01 NSC 9120 NSC9120 NSC9900 Neo-Delta-Cortef Nisolone Nor-Pred T.B.A. Ocu-Pred Ocu-Pred Forte Ophtho-Tate Orapred P0152_SIGMA P0637 P6004_SIGMA PRDL PRED-G Panafcortelone Paracortol Paracotol Pediapred Poly-Pred Precortalon Precortancyl Precortilon Precortisyl Pred Forte Pred Mild Predair Predair A Predair Forte Predalone 50 Predalone T.B.A. Predate Predate Tba Predate-50 Predcor-25 Predcor-50 Predcor-Tba Predisolone Sodium Phosphate Predne-Dome Prednelan Predni-Dome Prednicen Predniliderm Predniretard Prednis Prednisolona Prednisolona [INN-Spanish] Prednisolone (JP15/USP/INN) Prednisolone (anhydrous) Prednisolone Acetate Prednisolone Sodium Phosphate Prednisolone Tebutate Prednisolone [INN:BAN:JAN] Prednisolonum Prednisolonum [INN-Latin] Predonin Predonine Prelone Prenolone Prestwick0_000274 Prestwick1_000274 Prestwick2_000274 Prestwick3_000274 Prestwick_404 Rolisone S1737_Selleck SAM002264639 SMR000718761 SPBio_002367 Scherisolon Solone Steran Sterane Sterolone Supercortisol UNII-9PHQ9Y1OLM Ulacort Ultra Pred Ultracorten H Ultracortene H Ultracortene-H Ultracortene-Hydrogen Ultracortene-hydrogen ZINC03833821 component of Ataraxoid component of K-Predne-Dome delta(1)-Cortisol delta(1)-Dehydrocortisol delta(1)-Dehydrohydrocortisone delta(1)-Hydrocortisone delta(sup 1)-Cortisol delta(sup 1)-Dehydrocortisol delta(sup 1)-Dehydrohydrocortisone delta(sup 1)-Hydrocortisone delta-dehydrocortisol delta-dehydrohydrocortisone delta-hydrocortisone prednisolone | |
| | 13 | | Aspirin | approved, vet_approved | Phase 4, Phase 3, Phase 2 | 1152 | 50-78-2 | 2244 | 11126-35-5 11126-37-7 1oxr 2-(Acetyloxy)benzoate 2-(Acetyloxy)benzoic acid 2-Acetoxybenzenecarboxylic acid 2-Acetoxybenzoate 2-Acetoxybenzoic acid 2-Carboxyphenyl acetate 2349-94-2 26914-13-6 50-78-2 8-hour Bayer 98201-60-6 A 5376 A.S.A A.S.A. A.S.A. Empirin A.S.A. empirin A2093_SIGMA A3160_SIGMA A5376_SIGMA A6810_SIGMA AB1003266 AC 5230 AC1L1D8U AC1Q1LA0 ACETYLSALICYLIC ACID AI3-02956 AIN AKOS000118884 ASA Acenterine Acesal Acetal Acetard Aceticyl Acetilsalicilico Acetilum acidulatum Acetisal Acetol Acetonyl Acetophen Acetosal Acetosalic acid Acetosalin Acetoxybenzoic acid Acetylin Acetylsal Acetylsalicylate Acetylsalicylic acid Acetylsalicylsaeure Acetylsalicylsaure Acetylsalicylsäure Acetylsalycilic acid Acetyonyl Acetysal Acetysalicylic acid Acide acetylsalicylique Acido O-acetil-benzoico Acido acetilsalicilico Acidum acetylsalicylicum Acimetten Acisal Acylpyrin Adiro Aloxiprimum Asacard Asagran Asatard Ascoden-30 Aspalon Aspec Aspergum Aspir-Mox Aspirdrops Aspirin Aspirin (JP15/USP) Aspirin [BAN:JAN] Aspirina 03 Aspirine Asprin Aspro Aspro Clear Asteric Azetylsalizylsaeure Azetylsalizylsäure BIDD:GT0118 BRN 0779271 Bay-e-4465 Bayer Bayer Aspirin 8 Hour Bayer Buffered Bayer Extra Strength Aspirin For Migraine Pain Bayer Plus Benaspir Bi-prin Bialpirina Bialpirinia Bufferin C01405 CCRIS 3243 CHEBI:15365 CHEMBL25 CID2244 Caprin Cardioaspirin Cardioaspirina Cemirit Claradin Clariprin Colfarit Contrheuma retard Coricidin Crystar D00109 D001241 DB00945 Decaten Delgesic Dispril DivK1c_000555 Dolean pH 8 Duramax ECM EINECS 200-064-1 EU-0100038 Easprin Easprin (TN) Ecolen Ecotrin Empirin Empirin with Codeine Endosprin Endydol Entericin Enterophen | Enterosarein Enterosarine Entrophen Extren Globentyl Globoid HMS1920E13 HMS2090G03 HMS2091K13 HMS501L17 HSDB 652 Helicon I14-7505 IDI1_000555 Idragin Istopirin KBio1_000555 KBio2_001725 KBio2_002271 KBio2_004293 KBio2_004839 KBio2_006861 KBio2_007407 KBio3_002149 KBio3_002751 KBioGR_000398 KBioGR_002271 KBioSS_001725 KBioSS_002272 Kapsazal Kyselina 2-acetoxybenzoova Kyselina acetylsalicylova LS-143 Levius Lopac-A-5376 Lopac0_000038 MLS001055329 MLS001066332 MLS001336045 MLS001336046 Magnecyl Measurin Medisyl Micristin MolPort-000-871-622 NCGC00015067-01 NCGC00015067-04 NCGC00015067-09 NCGC00090977-01 NCGC00090977-02 NCGC00090977-03 NCGC00090977-04 NCGC00090977-05 NCGC00090977-06 NCGC00090977-07 NCI60_002222 NINDS_000555 NSC 27223 NSC27223 NSC406186 Neuronika Novid Nu-seals Nu-seals aspirin O-(Acetyloxy)benzoate O-(Acetyloxy)benzoic acid O-Acetoxybenzoate O-Acetoxybenzoic acid O-Acetylsalicylic acid O-Carboxyphenyl acetate O-accetylsalicylic acid O-acetylsalicylic acid PL-2200 Persistin Pharmacin Pirseal Polopirin Polopiryna Premaspin R16CO5Y76E [UNII] Rheumin tabletten Rheumintabletten Rhodine Rhonal Ronal S-211 SMR000059138 SP 189 SPBio_001838 SPECTRUM1500130 ST075414 Salacetin Salcetogen Saletin Salicylic acid acetate Salicylic acid, acetate Salospir Solfrin Solprin Solprin acid Solpyron Solupsan Spectrum2_001899 Spectrum3_001295 Spectrum4_000099 Spectrum5_000740 Spectrum_001245 Spira-Dine St. Joseph St. Joseph Aspirin for Adults Supac Tasprin Temperal Toldex Triaminicin Triple-sal UNII R16CO5Y76E UNII-R16CO5Y76E UNII=R16CO5Y76E UNM-0000306102 Vanquish WLN: QVR BOV1 XAXA Xaxa Yasta ZORprin acide 2-(acétyloxy)benzoïque acide acétylsalicylique aspirin cMAP_000006 component of Midol component of Synirin nchem.859-comp6 o-Acetoxybenzoic acid o-Carboxyphenyl acetate o-acetoxybenzoic acid o-carboxyphenyl acetate salicylic acid acetate ácido acetilsalicílico |
| | 14 | | Empagliflozin | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 133 | 864070-44-0 | | (1S)-1,5-anhydro-1-(4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl)-D-glucitol 1-chloro-4-(glucopyranos-1-yl)-2-(4-(tetrahydrofuran-3-yloxy)benzyl)benzene | |
| | 15 | | Prednisone | approved, vet_approved | Phase 4, Phase 1, Phase 2, Early Phase 1 | 1398 | 53-03-2 | 5865 | (1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione (8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione (8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione .delta. E .delta.(sup1)-Cortisone .delta.-Cortelan .delta.-Cortisone .delta.-Cortone .delta.-E .delta.1-Cortisone .delta.1-Dehydrocortisone .delta.sone 1,2-Dehydrocortisone 1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione 1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione 1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione 1-Cortisone 1-Dehydrocortisone 17,21-Dihydroxypregna-1,4-diene-3,11,20-trione 17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione 53-03-2 68-59-7 81552_FLUKA AC-11112 AC1L1LB2 AC1Q29EZ ACon0_000082 ACon1_000297 AI3-52939 Adasone Ancortone Apo-Prednisone Apo-prednisone BPBio1_000323 BRD-K85883481-001-04-2 BSPBio_000293 Betapar Bicortone Bio-0649 C07370 C21H26O5 CCRIS 2646 CHEBI:8382 CHEMBL635 CID5865 CPD001227202 Cartancyl Colisone Cortan Cortancyl Cortidelt Cotone DB00635 Dacorten Dacortin Decortancyl Decortin Decortisyl Dehydrocortisone Dekortin Delcortin Dellacort Dellacort A Delta Cortelan Delta E Delta E. Delta-Cortelan Delta-Dome Delta-cortelan Delta-cortisone Delta-cortone Delta-dome Deltacortene Deltacortisone Deltacortone Deltasone Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone Deltison Deltisona Deltisone Deltra Di-Adreson Diadreson EINECS 200-160-3 Econosone Encorton Encortone Enkortolon Enkorton Fernisone Fiasone HMS1568O15 HMS2090J13 HSDB 3168 Hostacortin In-Sone Incocortyl | Juvason Kortancyl LMST02030180 LS-1325 Liquid Pred Lisacort Lodotra MEGxm0_000443 MLS001061265 MLS001304073 MLS001335907 MLS001335908 MLS002154191 MLS002207083 Me-Korti Metacortandracin Meticorten Meticorten (Veterinary) Metrevet (Veterinary) MolPort-001-740-041 NCGC00090766-01 NCGC00090766-02 NCGC00090766-03 NCI-C04897 NCI60_000008 NSC 10023 NSC10023 Nisona Nizon Novoprednisone Nurison Orasone Origen Prednisone P1276 P6254_SIGMA PRD Panafcort Panasol Paracort Parmenison Pehacort Precort Predeltin Prednicen-M Prednicorm Prednicort Prednicot Prednidib Prednilonga Prednison Prednisona Prednisona [INN-Spanish] Prednisone Prednisone Intensol Prednisone [INN:BAN] Prednisonum Prednisonum [INN-Latin] Prednitone Prednizon Prednovister Presone Prestwick0_000077 Prestwick1_000077 Prestwick2_000077 Prestwick3_000077 Prestwick_405 Pronison Pronisone Rectodelt Retrocortine S1622_Selleck SAM002264641 SK-Prednisone SMR000718760 SMR001227202 SPBio_002214 Servisone Sone Sterapred Supercortil U 6020 UNII-VB0R961HZT Ultracorten Ultracortene WLN: L E5 B666 CV OV AHTTT&J A1 E1 FV1Q FQ Winpred Wojtab ZINC03875357 Zenadrid Zenadrid (veterinary) Zenadrid [veterinary] delta cortelan delta(sup 1)-Cortisone delta(sup 1)-Dehydrocortisone delta-1-Cortisone delta-1-Dehydrocortisone delta-Cortisone delta-Cortone | |
| | 16 | | Ritonavir | approved, investigational | Phase 4 | 883 | 155213-67-5 | 392622 | 1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate 155213-67-5 1hxw 1sh9 5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S)-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate 5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate 538, ABT A-84538 ABBOTT-84538 ABT 538 ABT 84538 ABT-538 ABT538 AC-733 AC1L94GB AKOS000280930 Abbott 84538 BIDD:GT0387 BIDD:PXR0023 Bio-0093 C07240 C37H48N6O5S2 CHEBI:45409 CHEMBL163 CID392622 CPD000466395 D00427 D019438 | DB00503 DRG-0244 FT-0082824 HMS2051B08 HSDB 7160 LS-148860 MLS000759541 MLS001424063 MolPort-000-883-877 N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-N~2~-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide NCGC00159462-02 NSC693184 Norvir Norvir (TM) Norvir (TN) Norvir Sec RIT RTV Ritonavir Ritonavir (JAN/USAN/INN) Ritonavir [USAN] Ritonavir is an inhibitor of HIV protease used to treat HIV infection and AIDS. Ritonavirum S1185_Selleck SAM001246783 SMR000466395 STK634209 ZINC03944422 ritonavir | |
| | 17 | | Pravastatin | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 150 | 81093-37-0 | 54687 | (+)-(3R,5R)-3,5-Dihydroxy-7-[(1S,2S,6S,8S,8ar)-6-hydroxy-2-methyl-8-{[(S)-2-methylbutyryl]oxy}-1,2,6,7,8,8a-hexahydro-1-naphthyl]heptanoic acid (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-1-Naphthaleneheptanoic acid 3beta-Hydroxycompactin 81093-37-0 81131-70-6 (hydrochloride salt) AC1L1HJL AC1Q5T3M BIDD:GT0773 BRD-K60511616-236-01-4 C01844 C23H36O7 CCRIS 7557 CHEMBL1144 CID54687 Compactin D08410 DB00175 Elisor Eptastatin FT-0082682 KS-5015 LS-94713 Lipostat Mevalothin Mevalotin Mevastatin Mevinolin | Oliprevin Pravachol Pravaselect Pravastatin (INN) Pravastatin Sodium Pravastatin Sodium Salt Pravastatin [INN:BAN] Pravastatin acid Pravastatin sodium Pravastatin tert-Octylamine Salt Pravastatina Pravastatina [Spanish] Pravastatine Pravastatine [French] Pravastatinum Pravastatinum [Latin] Pravator Pravator (TN) RMS-431 SQ-31,000 Selectin Selektine Selipran UNII-KXO2KT9N0G Vasten nchembio.301-comp7 nchembio790-comp15 pravastatin pravastatina pravastatine pravastatinum |
| | 18 | | Vildagliptin | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 157 | 274901-16-5 | 6918537 | (2S)-(((3-hydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile (2S)-1-[2-[(3-hydroxy-1-adamantyl)amino]acetyl]pyrrolidine-2-carbonitrile 1-[2-[(3-hydroxy-1-adamantyl)amino]acetyl]pyrrolidine-2-carbonitrile 2-Pyrrolidinecarbonitrile, 1-[[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-, (2S)- (9CI) 274901-16-5 AC1NQOUT AC1OCFK2 C502012 CHEBI:253127 CHEMBL142703 CHEMBL319819 CID11077541 CID5251896 CID6918537 D07080 DB04876 EQUA Equa FT-0082760 Galvu Galvus I11-0029 | Jalra LAF 237 LAF-237 LAF237 LS-193227 NVP-LAF 237 NVP-LAF-237 NVP-LAF237 SBB066750 UNII-I6B4B2U96P Vidagliptin (see Vildagliptin) Vildagliptin Vildagliptin (JAN/USAN/INN) Xiliarx equa galvus jalra laf 237 laf237 nvp-laf-237 nvp-laf237 s xiliarx | |
| | 19 | | Linagliptin | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 139 | 668270-12-0 | 10096344 | (R)-8-(3-Amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione (R)-8-(3-Aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methylquinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione 668270-12-0 BI 1356 BI-1356 BI-1356-BS CHEBI:49403 | CHEBI:499873 CHEMBL237500 CID 10096344 CID10096344 Linagliptin Ondero Tradjenta Trajenta | |
| | 20 | | Metformin | approved | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 1803 | 657-24-9 | 14219, 4091 | 1,1-Dimethyl biguanide 1,1-Dimethylbiguanide 3-(diaminomethylidene)-1,1-dimethylguanidine 657-24-9 AC1L1HE4 AKOS000121065 Apo-Metformin BIDD:GT0697 BPBio1_000009 BRD-K79602928-003-04-1 BSPBio_000007 BSPBio_002314 C07151 C4H11N5 CAS-1115-70-4 CCRIS 9321 CHEBI:6801 CHEMBL1431 CID4091 D04966 DB00331 DMGG Diabetosan Diabex Dimethylbiguanid Dimethylbiguanide Dimethylbiguanidine Dimethyldiguanide Dimethylguanylguanidine EINECS 211-517-8 Fluamine Flumamine Fortamet Gen-Metformin Glifage Gliguanid Glucophage Glucophage XR Glumetza Glycon HMS2089D19 HSCI1_000295 Haurymelin Haurymellin Islotin KBio2_002310 KBio2_004878 KBio2_007446 KBio3_002790 KBioGR_002310 | KBioSS_002312 LA-6023 LS-43899 Melbin Metformin Metformin (USAN/INN) Metformin HCL Metformin [USAN:INN:BAN] Metformina Metformina [DCIT] Metformina [Spanish] Metformine Metformine [INN-French] Metformine pamoate Metforminum Metforminum [INN-Latin] Metiguanide MolPort-002-929-560 MolPort-004-288-389 MolPort-005-767-418 Mylan-Metformin N,N-Dimethylbiguanide N,N-Dimethyldiguanide N,N-Dimethylimidodicarbonimidic diamide N,N-dimethylimidodicarbonimidic diamide N1,N1-Dimethylbiguanide NCGC00016564-01 NCGC00016564-02 NCGC00016564-03 NNDG Novo-Metformin Nu-Metformin PMS-Metformin Prestwick0_000004 Prestwick1_000004 Prestwick2_000004 Prestwick3_000004 Ran-Metformin Ratio-Metformin Riomet S2483_Selleck SPBio_001928 STK011633 Sandoz Metformin Siofor T5895664 Teva-Metformin UNII-9100L32L2N ZINC12859773 cMAP_000016 metformin metformin hydrochloride |
| | 21 | | Ethinyl Estradiol | approved | Phase 4, Phase 1 | 728 | 57-63-6 | 5991 | 17 alpha-Ethinylestradiol 17 alpha-Ethynylestradiol 17 alpha-Ethynyloestradiol 17 alpha-ethinyestradiol 17-Ethinyl-3,17-estradiol 17-Ethinyl-3,17-oestradiol 17-Ethinylestradiol 17-Ethynylestradiol 17-Ethynylestradiol ram 17-Ethynyloestradiol 17-alpha-Ethinyl-17-beta-estradiol 17-alpha-Ethynyl-17-beta-oestradiol 17-alpha-Ethynylestradiol 17-alpha-Ethynylestradiol-17-beta 17-alpha-ethynyl estradiol 17-ethinyl-3,17-estradiol 17-ethinyl-3,17-oestradiol 17-ethinylestradiol 17.alpha.-Ethinyl-17.beta.-estradiol 17.alpha.-Ethinylestradiol 17.alpha.-Ethynyl-17.beta.-oestradiol 17.alpha.-Ethynylestradiol 17.alpha.-Ethynylestradiol-l7.beta. 17.alpha.-Ethynyloestradiol 17.alpha.-Ethynyloestradiol-17.beta. 17a-Ethinyl-17b-estradiol 17a-Ethinylestradiol 17a-Ethynyl-17b-oestradiol 17a-Ethynylestradiol 17a-Ethynylestradiol-l7b 17a-Ethynyloestradiol 17a-Ethynyloestradiol-17b 17alpha-Ethinyl estradiol 17alpha-Ethinylestradiol 17alpha-Ethinylestradiol-17beta 17alpha-Ethynylestradiol 17alpha-Ethynyloestradiol 17alpha-Ethynyloestradiol-17beta 17α-ethynylestradiol 406932-93-2 46263_FLUKA 46263_RIEDEL 57-63-6 77538-56-8 AC-2169 AC1L1LK6 AI3-52941 Aethinyloestradiolum Aethinyoestradiol Aethinyoestradiol [German] Alora Amenoron Amenorone Anovlar BIDD:ER0162 BRN 2419975 Bio-0610 C07534 CCRIS 286 CHEBI:4903 CHEMBL691 CID5991 CPD000058319 Certostat Chee-O-Gen Chee-O-Genf Cyclosa D004997 D00554 DB00977 Dicromil Diognat-E Diogyn E Diogyn-E Diprol Dyloform E4876_SIGMA EE EE(sub 2) EE2 EINECS 200-342-2 EO ETHINYLESTRADIOL Effik Brand of Ethinyl Estradiol Ertonyl Esclim Esteed Estigyn Estinyl Estinyl (TN) Eston-E Estopherol Estoral Estoral (Orion) Estoral (VAN) Estoral [Orion] Estoral {[Orion]} Estorals Estradiol, Ethinyl Estradiol, Ethynyl Estring Estrogen Ethidol Ethinoral Ethinyl E2 Ethinyl Estradiol Hemihydrate Ethinyl Estradiol [USP] | Ethinyl Estradiol, (8 alpha)-Isomer Ethinyl Oestradiol Effik Ethinyl estradiol Ethinyl estradiol (USP) Ethinyl-Oestradiol Effik Ethinyl-Oestranol Ethinyl-oestranol Ethinylestradiol Ethinylestradiol (JP15/INN) Ethinylestradiol Jenapharm Ethinylestradiol [INN:BAN:JAN] Ethinylestradiolum Ethinylestradiolum [INN-Latin] Ethinylestriol Ethinyloestradiol Ethinyloestradiol [Steroidal oestrogens] Ethy 11 Ethynyl estradiol Ethynylestradiol Ethynylestradiol, Ethinyl Estradiol Ethynyloestradiol Eticyclin Eticyclol Eticylol Etinestrol Etinestryl Etinilestradiol Etinilestradiol [INN-Spanish] Etinilestradiolo Etinilestradiolo [DCIT] Etinoestryl Etistradiol Etivex Evra Feminone Fempatch Follicoral Ginestrene Gynodiol Gynolett HMS2051I19 HSDB 3587 Halodrin Hemihydrate, Ethinyl Estradiol Inestra Innofem Jenapharm Brand of Ethinyl Estradiol Jenapharm, Ethinylestradiol Kolpolyn LMST02010036 LS-231 Linoral Lynoral MLS000028479 MLS000758274 Marvelon Menolyn Menostar Mercilon Microfollin Microfollin Forte MolPort-001-794-636 NCGC00091533-01 NCGC00091533-04 NCGC00091533-05 NCI60_000234 NSC-10973 NSC10973 Neo-Estrone Nogest-S Novestrol OVULEN-21 OVULEN-28 Oradiol Orestralyn Orestrayln Organon Brand of Ethinyl Estradiol Ortho-Cyclen Ovex Oviol PUBERTAL ETHINYL ESTRADIOL STUDY Palonyl Perovex Primogyn Primogyn C Primogyn M Progynon C Progynon M Prosexol S1625_Selleck SAM001247008 SGCUT00127 SMR000058319 Schering Brand of Ethinyl Estradiol Spanestrin Thiuram E Thiuranide UNII-423D2T571U Vagifem Varnoline WLN: L E5 B666TTT&J E1 FQ F1UU1 OQ Ylestrol component of Demulen component of Oracon component of Ortrel ethinyl estradiol ethynyl estradiol to_000048 | |
| | 22 | | Glimepiride | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 234 | 93479-97-1 | 3476 | 1-((p-(2-(3-Ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido)ethyl)phenyl)sulfonyl)-3-(trans-4-methylcyclohexyl)urea 1-{[4-(2-{[(3-ethyl-4-methyl-2-oxo-2,5-dihydro-1H-pyrrol-1-yl)carbonyl]amino}ethyl)phenyl]sulfonyl}-3-(trans-4-methylcyclohexyl)urea 3-ethyl-4-methyl-N-[2-(4-{[(trans-4-methylcyclohexyl)carbamoyl]sulfamoyl}phenyl)ethyl]-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide 3-ethyl-4-methyl-n-(4-(n-((1r,4r)-4-methylcyclohexylcarbamoyl)sulfamoyl)phenethyl)-2-oxo-2,5-dihydro 4-ethyl-3-methyl-N-[2-[4-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide 64598P 93479-97-1 AB00513874 AC-476 AC1L1G0T Amarel Amaryl Amaryl (TN) Amaryl, Glista OD, Glimepiride Avaglim BPBio1_000751 BRD-K34776109-001-03-4 BRD-K42693031-001-01-8 BRN 5365754 BSPBio_000681 Bio-0049 C07669 C24H34N4O5S CAS-93479-97-1 CCRIS 7083 CHEBI:5383 CHEMBL1481 CID3476 CPD000466368 D00593 DB00222 Endial G2295_SIGMA Glimepirid Glimepirida Glimepirida [Spanish] Glimepiride (JAN/USP/INN) Glimepiride [USAN:BAN:INN] Glimepiridum Glimepiridum [Latin] | Glimepride Glimer Glimépiride Glymepirid HMS1570C03 HMS2052L03 HMS2090K18 HOE 490 Hoe-490 I06-0029 I06-2285 LS-136752 MLS000759495 MLS001076674 MLS001401419 MolPort-003-847-587 MolPort-003-987-461 MolPort-005-941-721 NCGC00016960-01 NCGC00161404-01 NCGC00161404-02 NCGC00181757-01 Novo-glimepiride Oprea1_382896 PMS-glimepiride Prestwick0_000651 Prestwick1_000651 Prestwick2_000651 Prestwick3_000651 Ratio-glimepiride Roname S1344_Selleck SAM001246710 SMR000466368 SPBio_002602 Sandoz glimepiride Solosa TL8005924 UNII-6KY687524K ZINC00537791 glimepiride | |
| | 23 | | Estradiol | approved, investigational, vet_approved | Phase 4, Phase 1, Phase 2 | 1318 | 50-28-2 | 5757, 53477783 | (+)-3,17b-Estradiol (17b)-Estra-1,3,5(10)-triene-3,17-diol (17beta)-Estra-1,3,5(10)-triene-3,17-diol .alpha.-Estradiol .alpha.-Oestradiol .beta.-Estradiol .beta.-Oestradiol 1,3,5[10]-Estratriene-3,17beta-diol 3-sulfate 1,3,5[10]-Estratriene-3,17beta-diol 3-sulphate 13b-Methyl-1,3,5(10)-gonatriene-3,17b-ol 17 beta-Estradiol 17-.BETA.-Estradiol 17-E 17-beta 17-beta-OH-estradiol 17-beta-estradiol 17.beta.-Estradiol 17.beta.-Oestradiol 17E 17b-Estradiol 17b-Oestradiol 17beta Oestradiol 17beta oestradiol 17beta-Estra-1,3,5(10)-triene-3,17-diol 17beta-Estradiol 17beta-Oestradiol 1jgl 1qkt 1qku 2d06 3,17-Epidihydroxyestratriene 3,17-beta-Estradiol 3,17-beta-Oestradiol 3,17.beta.-Estradiol 3,17b-Dihydroxyestra-1,3,5(10)-triene 3,17b-Estradiol 3,17beta-Estradiol 3,17beta-dihydroxy-1,3,5[10]-estratriene 3-sulfate 3,17beta-dihydroxy-1,3,5[10]-estratriene 3-sulphate 50-28-2 73459-61-7 873662-39-6 AC-10460 AC1L1L2K Aerodiol Agofollin Alora Altrad Amnestrogen Aquadiol B-Estradiol BEDOs BIDD:ER0125 BIDD:PXR0065 BPBio1_000532 BSPBio_000482 BSPBio_001065 Bardiol Benzhormovarine Beta-estradiol Bio-0812 Bio-E-Gel Bio1_000403 Bio1_000892 Bio1_001381 Bio2_000363 Bio2_000843 C00951 C18H24O2 CCRIS 280 CHEBI:16469 CHEMBL135 CID5757 CMC_11154 CPD-352 CPD000059126 Climaderm Climara Climara (TN) Climara Forte Compudose Compudose 200 Compudose 365 Corpagen D-3,17beta-Estradiol D-Estradiol D-Oestradiol D00105 DB00783 Dermestril Destradiol Dihydro-Theelin Dihydrofollicular hormone Dihydrofolliculin Dihydromenformon Dihydrotheelin Dihydroxyesterin Dihydroxyestrin Dihydroxyoestrin Dimenformon Diogyn Diogynets Divigel Divigel (TN) E 2 E 8875 E(sub 2) E0025 E1024_SIGMA E1132_SIGMA E2257_SIGMA E2758_SIGMA E8875_SIGMA EINECS 200-023-8 EU-0100503 Elestrin Encore Epiestriol 50 Esclim Estra-1,3,5(10)-triene-3,17b-diol Estrace Estrace (TN) Estraderm Estraderm (TN) Estraderm MX Estraderm TTS Estraderm TTS 100 Estraderm TTS 50 Estradiol Estradiol [USAN:INN] Estradiol-17 beta Estradiol-17-beta Estradiol-17.beta. Estradiol-17beta Estradiol-3,17beta Estradiolo Estradiolo [DCIT] Estradiolum Estradiolum [INN] Estradot Estraldine Estrapak 50 Estrasorb Estrasorb (TN) Estreva Estrifam Estring Estring (TN) Estring Vaginal Ring Estring vaginal ring Estroclim Estroclim 50 Estrodiolum Estrofem 2 Estrofem Forte Estrogel | Estrogel (TN) Estrogel HBF Estrovite Evamist Evorel Extrasorb Femanest Femestral Femestrol Femogen Fempatch Femtrace Femtran Follicyclin Gelestra Ginedisc Ginosedol GynPolar Gynergon Gynestrel Gynodiol Gynoestryl HMS1362E07 HMS1569I04 HMS1792E07 HMS1990E07 HMS2051C17 HMS2090E18 HSDB 3589 IDI1_002118 Innofem Innofem (TN) KBio2_000405 KBio2_002269 KBio2_002973 KBio2_004837 KBio2_005541 KBio2_007405 KBio3_000769 KBio3_000770 KBio3_002749 KBioGR_000405 KBioGR_002269 KBioSS_000405 KBioSS_002270 LMST02010001 LS-137 Lamdiol Lio-Oid Lopac0_000503 MLS000069494 MLS000758312 MLS001076331 Macrodiol Macrol Menest Menorest Menostar Microdiol MolPort-001-794-632 NCGC00091544-00 NCGC00091544-01 NCGC00091544-02 NCGC00091544-04 NCGC00091544-05 NCGC00091544-06 NCGC00091544-07 NCGC00091544-08 NCGC00091544-09 NCGC00091544-12 NCGC00179321-01 NCGC00179321-02 NSC-9895 NSC9895 Nordicol Oesclim Oestergon Oestra-1,3,5(10)-triene-3,17b-diol Oestradiol Oestradiol Berco Oestradiol R Oestradiol-17-beta Oestradiol-17.beta. Oestradiol-17beta Oestradiolum Oestrogel Oestroglandol Oestrogynal Ovahormon Ovasterol Ovastevol Ovociclina Ovocyclin Ovocycline Ovocylin Perlatanol Polyestradiol Prestwick0_000441 Prestwick1_000441 Prestwick2_000441 Prestwick3_000441 Prestwick_207 Primofol Profoliol Profoliol B Progynon Progynon DH Progynon-DH S-21400 S1709_Selleck SAM001247032 SK-Estrogens SL-1100 SMP1_000121 SMR000059126 SPBio_002421 Sandrena 1 Sandrena Gel Sisare Gel Spectrum5_002055 Syndiol Systen Tradelia Trial SAT Trocosone UNII-4TI98Z838E VIVELLE-DOT Vagifem Vagifem (TN) Vivelle Vivelle (TN) Zerella Zesteem Zesteen Zumenon [2,4,6,7-3H]-E2 [3H]-estradiol [3H]]estradiol b-Estradiol beta-Estradiol beta-Estradiol 3-sulfate beta-Estradiol 3-sulphate bmse000642 cMAP_000005 cis-Estradiol cis-Oestradiol component of Menrium delta-Estradiol delta-Oestradiol estradiol estradiol-17beta nchembio.168-comp3 nchembio.76-comp2 nchembio775-comp2 nchembio794-comp6 nchembio860-comp1 progynon | |
| | 24 | | Insulin Detemir | approved | Phase 4, Phase 3, Phase 1 | 195 | 169148-63-4 | 5311023 | | Insulin detemir recombinant Insulin,detemir,human | |
| | 25 | | Fenofibrate | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 170 | 49562-28-9 | 3339 | 2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid 1-methylethyl ester 49562-28-9 AB00052196 AC-4227 AC1L1FPK AKOS005107777 AZU, Fenofibrat AbZ Brand of Procetofen Abbott Brand of Procetofen Aliud Brand of Procetofen Ankebin Antara Antara (TN) Antara (micronized) Antara Micronized Procetofen Anto Brand of Procetofen Apo Feno Micro Apo Fenofibrate Apo-Feno-Micro Apo-Fenofibrate Apotex Brand of Procetofen Azupharma Brand of Procetofen BIDD:GT0574 BPBio1_000166 BRD-K50388907-001-05-6 BRN 2062462 BSPBio_000150 BSPBio_003162 Bouchara Brand of Procetofen C07586 C20H21ClO4 CAS-49562-28-9 CCRIS 7282 CHEBI:5001 CHEMBL672 CID3339 CIP-Fenofibrate CPD000058299 Controlip D00565 D011345 DB01039 Debat, Fenofibrate DivK1c_000557 EINECS 256-376-3 EU-0100486 Elasterate Elasterin F 6020 F6020_SIGMA FENOFIBRATE (MICRONIZED) FNF Fenobeta Fenobrate Fenofanton Fenofibrat AL Fenofibrat AZU Fenofibrat AbZ Fenofibrat FPh Fenofibrat Heumann Fenofibrat Hexal Fenofibrat Stada Fenofibrat ratiopharm Fenofibrat-ratiopharm Fenofibrate Fenofibrate (JAN/INN) Fenofibrate Debat Fenofibrate IDD-P Fenofibrate MSD Fenofibrate [INN:BAN] Fenofibrato Fenofibrato [INN-Spanish] Fenofibratum Fenofibratum [INN-Latin] Fenofibric acid Fenogal Fenoglide Fenomax Fenotard Finofibrate Fournier Brand of Procetofen Fulcro GNR Pharma Brand of Procetofen GNR-Pharma Brand of Procetofen GRS-027 Gate Brand of Procetofen Gen Fenofibrate Gen-Fenofibrate Genpharm Brand of Procetofen HMS1568H12 HMS1921B17 HMS2090G20 HMS2092B05 HMS501L19 Heumann Brand of Procetofen Heumann, Fenofibrat Hexal Brand of Procetofen Hexal, Fenofibrat I06-0048 IDI1_000557 Isopropyl (4'-(P-chlorobenzoyl)-2-phenoxy-2-methyl)propionate Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionate Isopropyl 2-(p-(p-chlorobenzoyl)phenoxy)-2-methylpropionate KBio1_000557 KBio2_001730 KBio2_004298 KBio2_006866 KBio3_002382 KBioGR_000706 KBioSS_001730 Knoll Brand of Procetofen LCP-Feno LCP-FenoChol LF 178 | LF-178 LF178 LS-121256 Lichtenstein Brand of Procetofen Lipanthyl Lipantil Lipantil (TN) Liparison Lipidex Lipidil Lipidil Micro Lipidil Supra Lipidil Ter Lipidil-Ter Lipifen Lipirex Lipoclar Lipofen Lipofen (TN) Lipofene Liposit Lipsin Lofibra Lopac-F-6020 Lopac0_000486 Luxacor MLS000028515 MLS001148191 MTW Brand of Procetofen MTW Fenofibrat MTW-Fenofibrat Merck dura Brand of Procetofen Micronized Procetofen, Antara MolPort-002-887-051 NCGC00015437-01 NCGC00015437-02 NCGC00015437-03 NCGC00015437-06 NCGC00015437-12 NCGC00021475-03 NCGC00021475-04 NCGC00021475-05 NCGC00021475-06 NCGC00021475-07 NCGC00021475-08 NINDS_000557 NSC 281319 NSC281319 Nolipax Novartis Brand of Procetofen Novo Fenofibrate Novo-Fenofibrate Novopharm Brand of Procetofen Nu Fenofibrate Nu Pharm Brand of Procetofen Nu-Fenofibrate Nu-Pharm Brand of Procetofen PMS Fenofibrate Micro PMS-Fenofibrate Micro Pharmascience Brand of Procetofen Pharmavit Phenofibrate Prestwick0_000275 Prestwick1_000275 Prestwick2_000275 Prestwick3_000275 Prestwick_217 Procetofen Procetofen Reliant Brand Procetofen, Antara Micronized Procetofene Proctofene Protolipan Q Pharm Brand of Procetofen Q-Pharm Brand of Procetofen Reliant Brand of Procetofen S1794_Selleck SAM002264613 SMR000058299 SPBio_001380 SPBio_002369 SPECTRUM1501010 ST085313 Schering Plough Brand of Procetofen Schering-Plough Brand of Procetofen Secalip Sedufen Spectrum2_001390 Spectrum3_001431 Spectrum4_000413 Spectrum5_001479 Spectrum_001250 Stada, Fenofibrat Stadapharm Brand of Procetofen Supralip TL8003296 TRICOR (MICRONIZED) Tricor Tricor (TN) Triglide Triglide (TN) Trilipix UNII-U202363UOS United Drug Brand of Procetofen ZINC00584092 betapharm Brand of Procetofen ct Arzneimittel Brand of Procetofen ct-Arzneimittel Brand of Procetofen durafenat fenofibrat von ct fenofibrate fenofibric acid isopropyl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate nchembio790-comp24 ratiopharm Brand of Procetofen | |
| | 26 | | Pioglitazone | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 441 | 111025-46-8 | 4829 | (+-)-5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione (+-)-5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione (+/-)-5-[[4-[2-(5-Ethyl-2-pyridinyl)-ethoxy]phenyl]methyl]-2,4-thiazolidinedione (+/-)-5-[p-[2-(ethyl-2-pyridyl)ethoxy]benzyl]-2,4-thiazolidinedione 105355-27-9 111025-46-8 198077-89-3 2,4-Thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]- (9CI) 5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione 5-(4-(2-(5-ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione 5-[4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl]thiazolidine-2,4-dione 5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-thiazolidinedione 5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione 5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]thiazolidine-2,4-dione 5-[[4-[2-[(5-ethyl-2-pyridyl)]ethoxy]phenyl]methyl]thiazolidine- 2,4-dione 5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-1,3-thiazolidine-2,4-dione AB1004597 AC-1021 AC1L1J1Q AD 4833 AD-4833 Actos Actos (TN) Actost BRD-A48430263-003-02-4 BSPBio_002723 C07675 C19H20N2O3S CHEBI:8228 CHEMBL595 CID4829 D08378 DB01132 Duetact Glustin HMS2089H14 HS-0047 | HSDB 7322 I06-0089 KBio2_002103 KBio2_004671 KBio2_007239 KBio3_001943 KBioGR_001619 KBioSS_002103 LS-151327 MolPort-002-508-211 NCGC00163128-01 NCGC00163128-02 Pioglitazona Pioglitazona [INN-Spanish] Pioglitazone Pioglitazone HCl Pioglitazone Hydrochloride Pioglitazone [BAN:INN] Pioglitazone [Ban:Inn] Pioglitazone [INN:BAN] Pioglitazonum Pioglitazonum [INN-Latin] SPBio_001897 Spectrum2_001679 Spectrum3_001002 Spectrum4_001130 Spectrum5_001480 Spectrum5_002067 Spectrum_001623 U 72107 U 72107A U-72107 U72,107A UNII-X4OV71U42S Zactos nchembio790-comp10 pioglitazone (INN) pioglitazone HCl | |
| | 27 | | Iron | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 1165 | 7439-89-6 | 23925 | 02583_FLUKA 12310_ALDRICH 12310_RIEDEL 129048-51-7 14067-02-8 161135-39-3 190454-13-8 195161-83-2 199281-22-6 209309_ALDRICH 209309_SIAL 255637_ALDRICH 266213_ALDRICH 266256_ALDRICH 267945_ALDRICH 267953_ALDRICH 26Fe 338141_ALDRICH 356808_ALDRICH 356824_ALDRICH 356832_ALDRICH 39344-71-3 3ZhP 413054_ALDRICH 443783-52-6 44890_ALDRICH 44890_FLUKA 675141-17-0 70884-35-4 73135-38-3 7439-89-6 8011-79-8 8053-60-9 AC1L2N38 ATW 230 ATW 432 Ancor B Ancor en 80/150 Armco iron Atomel 28 Atomel 300M200 Atomel 500M Atomel 95 Atomiron 44MR Atomiron 5M Atomiron AFP 25 Atomiron AFP 5 C00023 C3518_SIAL C3518_SIGMA CCRIS 1580 CHEBI:18248 CID23925 Carbonyl iron Copy Powder CS 105-175 D007501 DB01592 DSP 1000 DSP 128B DSP 135 DSP 135C DSP 138 Diseases (animal), iron overload Diseases, iron overload EF 1000 EF 250 EFV 200/300 EFV 250 EFV 250/400 EINECS 231-096-4 | Ed-In-Sol Eisen Electrolytic iron F 60 (metal) FE FT 3 (element) Fe Fe-40 Fe1+ Feronate Ferretts Ferro-Caps Ferro-Time Ferrousal Ferrovac E Ferrum Ferrum metallicum GS 6 HF 2 (element) HL (iron) HQ (metal) HS (iron) HS 4849 HSDB 604 Hemocyte Hierro Hoeganaes ATW 230 Hoeganaes EH IRMM524A_FLUKA IRMM524B_FLUKA IRON Iron (Fe) Iron (Fe1+) Iron ion (Fe+) Iron ion(1+) Iron monocation Iron powder Iron standard for AAS Iron(1+) Iron(1+) ion Iron(III) nitrate solution Iron, carbonyl Iron, electrolytic Iron, elemental Iron, ion (Fe1+) Iron, ion (Fe1+) (8CI,9CI) Iron, reduced LOHA LS-3196 MolPort-003-925-001 NC 100 PZh-1M3 PZh-2 PZh1M1 PZh2M PZh2M1 PZh2M2 PZh3 PZh3M PZh4M PZhO Reduced iron Remko SUY-B 2 Siderol UNII-E1UOL152H7 Vitedyn-Slo Yieronia fer ferrous iron hierro | |
| | 28 | | Rosiglitazone | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 220 | 122320-73-4 | 77999 | (RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion (±)-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione 122320-73-4 2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]- (9CI) 5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione 5-((4-(2-Methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate 5-(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}benzyl)-1,3-thiazolidine-2,4-dione 5-[4-[2-(N-Methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione 5-[[4-[2-(methyl-(2-pyridyl)amino)ethoxy]phenyl]methyl] thiazolidine-2,4-dione 5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione AC-3459 AC1L2U9N Avandia BRD-A97437073-001-02-3 BRD-A97437073-001-03-1 BRL49653 BSPBio_002693 Brl 49653 Brl-49653 C18H19N3O3S CID77999 D08491 DB00412 Gaudil Gaudil (TN) HMS1922J11 HMS2094O13 HSDB 7555 I06-0141 IDMB (1uM BRL49653, 1uM Dexamethasone, 0.5uM IBMX, 10ug/mL Insulin) KBio2_002183 KBio2_004751 KBio2_007319 KBio3_001913 | KBioGR_001609 KBioSS_002183 LS-151340 MolPort-002-508-212 NCGC00095124-01 NCGC00095124-02 NCGC00095124-03 RGZ RSG Rosi Rosigilitazone Rosigliazone maleate Rosiglitazon Rosiglitazona Rosiglitazone Rosiglitazone (INN) Rosiglitazone [INN:BAN] Rosiglitazone maleate Rosiglitazonum Rosiglizole S00306 SPBio_001142 SPECTRUM1504263 STOCK6S-23924 Spectrum2_001241 Spectrum3_000997 Spectrum4_001125 Spectrum5_001464 Spectrum_001703 TDZ 01 UNII-05V02F2KDG [3H]rosiglitazone rosiglitazona rosiglitazone rosiglitazone (Avandia) rosiglitazonum |
| | 29 | | Simvastatin | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 519 | 79902-63-9 | 54454 | (+)-Simvastatin (1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate 2,2-Dimethylbutanoic acid (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester 2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one 2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one 79902-63-9 AC-1530 AC1L1H1F AKOS005111006 ARONIS24119 BCBcMAP01_000007 BIDD:GT0769 BPBio1_001001 BRD-K22134346-001-05-8 BRN 4768037 BSPBio_000909 BSPBio_002337 Bio-0672 Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,*aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester C25H38O5 CCRIS 7558 CHEBI:9150 CHEMBL1064 CID54454 CPD000718785 Cholestat Coledis Colemin Corolin D00434 D019821 DRG-0320 Denan DivK1c_006991 Eucor HMS1570N11 HMS1922H13 HMS2089D12 HMS2093E06 HSDB 7208 InChI=1/C25H38O5/c1-6-25(4,5)24(28)30-21-12-15(2)11-17-8-7-16(3)20(23(17)21)10-9-19-13-18(26)14-22(27)29-19/h7-8,11,15-16,18-21,23,26H,6,9-10,12-14H2,1-5H3/t15-,16-,18+,19+,20-,21-,23-/m0/s1 KBio1_001935 KBio2_002197 KBio2_004765 KBio2_007333 KBio3_001557 KBioGR_001244 KBioSS_002197 KS-1113 Kolestevan L 644128-000U LS-46264 Labistatin Lipex Lipinorm Liponorm Lipovas Lodales MK 0733 MK 733 MK-0733 MK-733 MK733 MLS001304029 MLS001333077 MLS001333078 | MLS002154038 Medipo Modutrol MolPort-002-507-345 MolPort-002-885-862 NCGC00017324-01 NCGC00017324-02 NCGC00017324-03 Nivelipol Nor-Vastina Pantok Pepstatin Prestwick0_000865 Prestwick1_000865 Prestwick2_000865 Prestwick3_000865 Prestwick_171 Rechol Rendapid S1792_Selleck S6196_SIGMA SAM002589969 SMR000718785 SPBio_001881 SPBio_002830 SPECTRUM1504236 STK801938 Simcor Simovil Simvast CR Simvastatin Simvastatin & Primycin Simvastatin (JAN/USP/INN) Simvastatin [USAN:INN:BAN] Simvastatin [Usan:Ban:Inn] Simvastatin lactone Simvastatin, Compactin Simvastatina Simvastatina [Spanish] Simvastatine Simvastatine [French] Simvastatinum Simvastatinum [Latin] Simvotin Sinvacor Sinvascor Sivastin SpecPlus_000895 Spectrum2_001671 Spectrum3_000669 Spectrum4_000632 Spectrum5_001428 Spectrum_001717 Statin Synvinolin TNP00259 UNII-AGG2FN16EV Valemia Vasotenal Velostatin Vytorin ZINC03780893 Zocor Zocor (TN) Zocor, Simlup, Simcard, Simvacor, Simvoget, Zorced, Simvastatin Zocord [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate butanoic acid, 2,2-dimethyl-,1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)-ethyl]-1-naphthalenyl ester, [1S-[1 alpha,3 alpha,7 beta,8 beta(2S*,4S*),-8a beta nchembio790-comp16 simvastatin |
| | 30 | | Insulin Aspart | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 442 | 116094-23-6 | 16132418 | (AspB28)-human insulin 1024611-56-0 116094-23-6 139532-40-4 28(sup B)-L-Aspartic acid-insulin (human) 877034-90-7 AspB28-insulin (human) Aspart Aspart Insulin Aspart insulin B28-Asp-insulin B28-Aspart-Insulin INA-X 14 | INA-X14 Insulin X14 Insulin aspart Insulin aspart [USAN] Insulin aspart protamine recombinant Insulin aspart recombinant Insulin, Asp(B28) LS-185932 NovoLog NovoMix 30 NovoRapid NovoRapid 30 Mix Novolog mix 70/30 UNII-D933668QVX | |
| | 31 | | Benzocaine | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 2016 | 1994-09-7, 94-09-7 | 2337 | (p-(Ethoxycarbonyl)phenylamine 06952_FLUKA 112909_ALDRICH 112909_SIAL 1333-08-0 23239-88-5 23239-88-5 (hydrochloride) 4 Aminobenzoic Acid Ethyl Ester 4-(Ethoxycarbonyl)aniline 4-(Ethoxycarbonyl)phenylamine 4-14-00-01129 (Beilstein Handbook Reference) 4-Aminobenzoate 4-Aminobenzoic acid 4-Aminobenzoic acid ethyl ester 4-Aminobenzoic acid, ethyl ester 4-Carbethoxyaniline 4-amino-benzoic acid ethyl ester 4-aminobenzoic acid ethyl ester 71123-91-6 94-09-7 94-09-7 (Parent) A0271 AB00051923 AC1L1DGC AC1Q341A AC1Q64JE AE-562/40377256 AI3-02081 AKOS000119763 AR-1H9065 Acetate, Benzocaine Aethoform Aethylium paraminobenzoicum Amben ethyl ester Americaine Anaesthan-syngala Anaesthesin Anaesthesinum Anaesthin Anestezin Anestezin [Russian] Anesthesin Anesthesine Anesthone BB_SC-0019 BPBio1_001017 BRD-K75466013-001-05-2 BRN 0638434 BSPBio_000923 BSPBio_001908 Baby Anbesol Bensokain Benzoak Benzocaina Benzocaina [INN-Spanish] Benzocaine Benzocaine (USP/INN) Benzocaine Acetate Benzocaine Formate Benzocaine Hydrobromide Benzocaine Hydrochloride Benzocaine Methanesulfonate Benzocaine [INN:BAN] Benzocainum Benzocainum [INN-Latin] Benzoic acid, 4-amino-, ethyl ester Benzoic acid, 4-amino-, ethyl ester, hydrochloride Benzoic acid, amino-, ethyl ester Benzoic acid, p-amino-, ethyl ester C07527 CAS-94-09-7 CHEBI:116735 CHEMBL278172 CID2337 Caswell No. 430A Chloraseptic D001566 D00552 DB01086 Dermoplast Diet Ayds DivK1c_000932 E1501_SIGMA EINECS 202-303-5 EPA Pesticide Chemical Code 097001 ETHYL-P-AMINOBENZOATE Ethoform Ethoforme Ethyl 4-aminobenzoate Ethyl 4-aminobenzoate hydrochloride Ethyl 4-aminobenzoic acid Ethyl Aminobenzoate Ethyl PABA | Ethyl aminobenzoate Ethyl aminobenzoate (JP15) Ethyl aminobenzoate (VAN) Ethyl aminobenzoic acid Ethyl p-Aminobenzoate Ethyl p-Aminophenylcarboxylate Ethyl p-aminobenzenecarboxylate Ethyl p-aminobenzoate Ethyl p-aminobenzoic acid Ethyl p-aminophenylcarboxylate Ethylester kyseliny p-aminobenzoove Ethylester kyseliny p-aminobenzoove [Czech] Ethylis aminobenzoas Formate, Benzocaine HMS1570O05 HMS1920G09 HMS2091M11 HMS502O14 HSDB 7225 Hurricaine Hydrobromide, Benzocaine Hydrochloride, Benzocaine I05-0204 IDI1_000932 Identhesin KBio1_000932 KBio2_000474 KBio2_003042 KBio2_005610 KBio3_001408 KBioGR_000658 KBioSS_000474 Keloform LS-35847 MLS001331704 MLS002153970 Methanesulfonate, Benzocaine MolPort-000-871-526 NCGC00016352-01 NCGC00094598-01 NCGC00094598-02 NINDS_000932 NSC 122792 NSC 41531 NSC41531 NSC4688 Norcain Norcaine Norcainum Oprea1_750694 Oprea1_827402 Ora-jel Orabase-B Orthesin Otocain Outgro Parathesin Parathesin (TN) Parathesine Prestwick0_000712 Prestwick1_000712 Prestwick2_000712 Prestwick3_000712 Prestwick_991 SMR000059025 SPBio_000134 SPBio_002844 SPECTRUM1500139 STK043620 Slim Mint Gum Solarcaine Solu H Spectrum2_000117 Spectrum3_000314 Spectrum4_000249 Spectrum5_000860 Spectrum_000074 Topcaine UNII-U3RSY48JW5 WLN: ZR DVO2 ZINC12358719 benzocaine ethylaminobenzoate-4 h-4-abz-oet nchembio.182-comp4 p-(Ethoxycarbonyl)aniline p-Aminobenzoate p-Aminobenzoic acid p-Aminobenzoic acid ethyl ester p-Aminobenzoic acid, ethyl ester p-Aminobenzoic ethyl ester p-Carbethoxyaniline p-Ethoxycarboxylic Aniline p-Ethoxycarboxylic aniline | |
| | 32 | | Methylprednisolone | approved, vet_approved | Phase 4, Phase 2, Phase 1 | 1193 | 83-43-2 | 6741 | (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one (6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione (6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione (6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione .DELTA.1-6.alpha.-Methylhydrocortisone 1-Dehydro-6alpha-methylhydrocortisone 1-dehydro-6alpha-Methylhydrocortisone 1-dehydro-6α-methylhydrocortisone 11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione 11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione 11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 121673-01-6 4-08-00-03498 (Beilstein Handbook Reference) 46436_FLUKA 46436_RIEDEL 570-35-4 6 Methylprednisolone 6-Methylprednisolone 6-alpha-Methylprednisolone 6.alpha.-Methylprednisolone 6923-42-8 6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione 6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione 6alpha-Methylprednisolone 6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione 83-43-2 AC1L1N7A Artisone-Wyeth Artisone-wyeth BPBio1_000174 BRD-K35240538-001-03-1 BRN 2340300 BSPBio_000158 Besonia Bio-0658 CHEBI:6888 CHEMBL650 CID6741 CPD000058330 D00407 D008775 DB00959 Depo-Medrol (acetate) Dopomedrol EINECS 201-476-4 Esametone Firmacort HMS1568H20 HMS2090B13 HSDB 3127 LMST02030178 LS-118498 Lemod M0639_SIGMA M1665 MEPRDL MLS000028541 MLS001148159 MLS002207191 Medesone Medixon Medlone 21 | Medrate Medrol Medrol (TN) Medrol Adt Pak Medrol Dosepak Medrol adt pak Medrol dosepak Medrol, Solu-Medrol, Medrone, Methylprednisolone Medrone Mesopren Metastab Methyleneprednisolone Methylprednisolon Methylprednisolone Methylprednisolone (JP15/USP/INN) Methylprednisolone [USAN:INN:BAN:JAN] Methylprednisolone, 6-alpha Methylprednisolonum Methylprednisolonum [INN-Latin] Metilbetasone Metilprednisolona Metilprednisolona [INN-Spanish] Metilprednisolone Metilprednisolone [DCIT] Metilprednisolone [Dcit] Metipred Metrisone Metrocort Metysolon Moderin MolPort-002-528-554 NCGC00022735-03 NCI60_001657 NSC-19987 NSC19987 Nirypan Noretona Predni N Tablinen Prednol- L Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI) Prestwick0_000279 Prestwick1_000279 Prestwick2_000279 Prestwick3_000279 Prestwick_622 Promacortine Reactenol S1733_Selleck SAM002589984 SMR000058330 SPBio_002377 Sieropresol Solomet Summicort Suprametil U 7532 UNII-X4W7ZR7023 Urbason Urbasone Wyacort ZINC03875560 delta(1)-6alpha-Methylhydrocortisone delta(sup 1)-6-alpha-Methylhydrocortisone methylprednisolone methylprenisolone |
| | 33 | | Nitroglycerin | approved, investigational | Phase 4 | 156 | 55-63-0 | 4510 | 1,2,3-Propanetrioltrinitrate 1,2,3-Propanetriyl nitrate 100292-13-5 105469-31-6 55-63-0 80066-48-4 8013-23-8 9010-02-0 AC1L1IBV Adesitrin Aldonitrin Angibid Angiolingual Angiplex Anglix Angonist Angorin Anogesic Aquo-Trimitrosan BIDD:GT0142 BRN 1802063 Blasting gelatin Blasting oil Buccal Buccard C07455 C3H5N3O9 CCRIS 4089 CHEBI:28787 CHEMBL730 CID4510 CPD-143 Cardabid Cardamist Cardinit Cardiodisco Cellegesic Chitamite Colenitral Cordipatch Corditrine Coro-Nitro D00515 D005996 DB00727 Dauxona Deponit Deponit 5 Deponit TTS 10 Deponit TTS 5 Deponit-5 Diafusor Discotrine Dynamite EINECS 200-240-8 Epinitril GTN GTN-Pohl Gepan Nitroglicerin Gilucor nitro Gilustenon Glonoin Glycerin trinitrate Glycerine trinitrate Glycerintrinitrate Glycerol trinitrate Glycerol, nitric acid triester Glyceroli trinitratis Glyceroltrinitraat Glyceroltrinitrat Glyceryl Glyceryl nitrate Glyceryl trinitrate Glycerylnitrat Glytrin HMS2094M15 HSDB 30 Herwicard Herzer IMX-150 Klavikordal LS-7741 Lenitral Lentonitrina MED-2002 MQX-503 Mi-Trates Millisrol Minitram Minitran Minitran (TN) Minitro Mionitrat Myocon Myoglycerin Myovin NG NITRO IV NK-843 NTG Natispray Neos nitro OPT Niglin Niglycon Niong Niong Retard Nirmin Nit-Ret Nitora Nitradisc Nitradisc Pad Nitradisc TTS Nitrangin Nitrek Nitriderm Nitriderm TTS Nitrine-TDC Nitro Bid Nitro Dur Nitro Dur TTS Nitro Mack Retard Nitro Retard Nitro Rorer Nitro-Bid Nitro-Dur 10 Nitro-Dur 5 Nitro-Gesanit Retard Nitro-M-Bid Nitro-Mack Retard Nitro-Par Nitro-Pflaster Nitro-Span Nitro-Time Nitro-bid (TN) Nitro-dur Nitro-dur (TN) Nitro-lent NitroBid NitroCor | NitroDur NitroMist NitroQuick NitroQuik Nitroard Nitrobaat Nitrobid Oint Nitrobukal Nitrocap NitrocapT.D NitrocapT.D. Nitrocard Nitrocerin Nitrocine Nitrocine 5 Nitroclyn Nitrocontin Nitrocontin Continus Nitrocot Nitroderm Nitroderm TTS Nitroderm TTS Ext Nitroderm TTS-5 Nitrodisc Nitrodyl Nitrodyl TTS Nitrogard Nitrogard-SR Nitroglicerina Nitrogliceryna Nitroglin Nitroglycerin Nitroglycerin (NG) Nitroglycerin ointment Nitroglycerin-ACC Nitroglycerine Nitroglycerol Nitroglyn Nitroject Nitrol Ointment Nitrolan Nitroletten Nitrolin Nitrolingual Nitrolingual Spray Nitrolowe Nitromack Retard Nitromed Nitromel Nitromex Nitromint Nitromint Aerosol Nitromint Retard Nitromist Nitromist (TN) Nitronal Aqueous Nitronet Nitrong Nitrong Retard Nitrong parenteral Nitrong-SR Nitropatch Nitropen Nitropercuten Nitroperlinit Nitroplast Nitroprol Nitropront Nitroprontan Nitrorectal Nitroretard Nitrorex Nitrospan Nitrostabilin Nitrostat Nitrovis Nitrozell retard Nysconitrine Percutol Percutol Oint Percutol Oint. Perganit Perglottal Perlinganit Plastranit Polnitrin Propane-1,2,3-triyl trinitrate RCRA waste no. P081 Ratiopharm Rectogesic SDM No. 17 SK-106N SK-866 SK-878 Soup Spirit of glonoin Susadrin Suscard Sustac Sustak Sustonit TNG Temponitrin Top-Nitro Transderm Nitro Transderm nitro Transderm-N TTS Transderm-Nitro TTS Transderm-nitro Transderm-nitro (TN) Transiderm-nitro Tridil Tridil sublin Trinalgon Trinipatch Triniplas Trinitrate, Glyceryl Trinitrin Trinitrin Tablets Trinitrina Erba Trinitrine Trinitroglycerin Trinitroglycerol Trinitrol Trinitrolong Trinitron Trinitrosan Turicard UN0143 UN0144 UN1204 UN3064 UN3319 UNII-G59M7S0WS3 Vascana Vasoglyn Vasolator Vernies Willong c0061 nitroglycerin |
| | 34 | | Pancrelipase | approved | Phase 4, Phase 2, Phase 3, Phase 1 | 970 | 53608-75-6 | | 1,4-alpha-D- glucan glucanohydrolase PA | Pancreatic alpha-amylase precursor Pancrelipase (amylase lipase protease) |
| | 35 | | Insulin Glargine | approved | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 528 | 160337-95-1 | | Insulin Glargine (rDNA origin) Insulin glargine recombinant | |
| | 36 | | Insulin Lispro | approved | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 240 | 133107-64-9 | | Insulin lispro (genetical recombination) Insulin lispro (rDNA origin) Insulin lispro protamine | Insulin lispro protamine recombinant Insulin lispro recombinant Insulin,lispro,human/rDNA Insulin,lispro,protamine/rDNA | |
| | 37 | | Zinc | approved | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 2296 | 7440-66-6 | 32051, 23994 | | | 38 | | Acarbose | approved, investigational | Phase 4, Phase 3, Phase 1, Phase 2 | 85 | 56180-94-0 | 441184 | (2R,3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol (2R,3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4S,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol (3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol 1,4-DEOXY-4-((5-HYDROXYMETHYL-2,3,4-TRIHYDROXYCYCLOHEX-5,6-ENYL)AMINO)FRUCTOSE 1agm 1gah 1k1y 1lf9 1ukt 4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-alpha-D-glucopyranosyl-(1->4)-alpha-D-glucopyranosyl-(1->4)-D-glucopyranose 4,6-dideoxy-4-{[(1S,4S,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-alpha-D-glucopyranosyl-(1->4)-alpha-D-glucopyranosyl-(1->4)-D-glucose 56180-94-0 AC1L26GM AC1L9APL AC1L9G0J AC1L9HYX AC1NAU1X AC1OCEJZ ACI-(1-4)GLD-(1-4)GLC-(1-4)GLB ACR Acarbosa Acarbosa [INN-Spanish] Acarbose Acarbose (JAN/USAN/INN) Acarbose [USAN:BAN:INN:JAN] Acarbosum Acarbosum [INN-Latin] Alpha-Acarbose BAY-g 5421 BB_NC-1311 Bay g 5421 Bay-g-5421 Beta-Acarbose C06802 C25H43NO18 CHEBI:2376 CHEBI:506767 CHEMBL1566 | CHEMBL394434 CHEMBL569486 CID10627975 CID41774 CID441184 CID4432690 CID444254 CID445421 CPD000466376 D00216 DB00284 EINECS 260-030-7 Glucobay Glucor HMC-(1-4)AGL-(1-4)GLC-(1-4)GLC HMS2051F03 HMS2093I22 LS-71702 MLS000759506 MLS001424056 MolPort-002-507-369 MolPort-003-844-373 NCGC00096061-01 NCGC00096061-02 NCGC00160515-01 O-4,6-Dideoxy-4-(((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-alpha-D-glucopyranosyl-(1-4)-O-alpha-D-glucopyranosyl-(1-4)-D-glucose O-4,6-Dideoxy-4-(((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-alpha-D-glucopyranosyl-(1->4)-O-alpha-D-glucopyranosyl-(1->4)-D-glucose O-4,6-Dideoxy-4-(((1S-(1alpha,4alpha,5beta,6alpha))-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-alpha-D-glucopyranosyl-(1-4)-O-alpha-D-glucopyranosyl-(1-4)-D-glucose Prandase Prandase, Precose, Glucobay, Bay-g 5421, Acarbose Precose Precose (TN) QPS S1271_Selleck SAM001246733 SMR000466376 SPECTRUM1505172 STK801930 UNII-T58MSI464G acarbose |
| | 39 | | Everolimus | approved | Phase 4, Phase 2, Phase 1 | 1940 | 159351-69-6 | 6442177 | (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone (1R,9S,12S,15R,16E,23S,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriacont (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34as)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethy 07741_FLUKA 159351-69-6 40-O-(2-hydroxyethyl)-rapamycin 42-O-(2-Hydroxyethyl)rapamycin Afinitor CERTICAN(R) CHEMBL1201755 Certican D02714 DB01590 | Everolimus Everolimus (JAN/USAN/INN) Everolimus [USAN] LS-143292 MolPort-003-847-342 MolPort-003-925-588 NCGC00167512-01 NVP-RAD-001 RAD 001 RAD-001 RAD-001C RAD001 RAD001, SDZ-RAD, Certican, Zortress, Afinitor, Everolimus S1120_Selleck SDZ-RAD UNII-9HW64Q8G6G Zortress everolimus |
| | 40 | | Glipizide | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 38 | 29094-61-9 | 3478 | 1-Cyclohexyl-3-((p-(2-(5-methylpyrazinecarboxamido)ethyl)phenyl)sulfonyl)urea 1-Cyclohexyl-3-{4-[2-(5-methylpyrazine-2-carboxamido)ethyl]phenylsulfonyl}urea 1-cyclohexyl-3-({p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl}sulfonyl)urea 172964-66-8 29094-61-9 29094-66-4 30553_FLUKA 38777-27-4 AC-15789 AC1L1G0Z AC1Q2OG0 Aldiab Alphapharm Brand of Glipizide BIDD:GT0476 BPBio1_000224 BRD-K12219985-001-04-8 BRN 0903495 BSPBio_000202 BSPBio_001349 Bio-0161 Bio1_000074 Bio1_000563 Bio1_001052 Bio2_000069 Bio2_000549 C21H27N5O4S CAS-29094-61-9 CBiol_001788 CHEBI:239286 CHEMBL1073 CID3478 CP 28,720 CP 28720 CP-28720 CPD000058455 D00335 D005913 DB01067 Digrin Dipazide EINECS 249-427-6 EU-0100621 G-117 G117_SIGMA Glibenese Glibenese Brand of Glipizide Glibetin Glican Glide Glidiab Glidiazinamide Glipid Glipizida Glipizida [INN-Spanish] Glipizide Glipizide (USP/INN) Glipizide Extended-Release Tablets Glipizide Kenfarma Brand Glipizide [USAN:BAN:INN] Glipizidum Glipizidum [INN-Latin] Gluco-Rite Glucolip Glucotrol Glucotrol (TN) Glucotrol XL Glucotrol XL, Glucotrol, Glipizide Glucozide Glupitel Glupizide Glyde Glydiazinamide Glypidizine | HMS1361D11 HMS1568K04 HMS1791D11 HMS1989D11 HMS2089C21 HMS2093J09 I06-0186 I06-1985 IDI1_033819 K 4024 K-4024 K4024 KBio2_000069 KBio2_002637 KBio2_005205 KBio3_000137 KBio3_000138 KBioGR_000069 KBioSS_000069 KS-1068 Kenfarma Brand of Glipizide LS-159679 Lacer Brand of Glipizide Lilly Brand of Glipizide Lopac-G-117 Lopac0_000621 MLS000069386 MLS001148176 Melizide Metaglip Mindiab Minidab Minidiab Minodiab MolPort-002-885-830 MolPort-003-666-685 N-(2-{4-[(cyclohexylcarbamoyl)sulfamoyl]phenyl}ethyl)-5-methylpyrazine-2-carboxamide N-(4-(beta-(5-Methylpyrazine-2-carboxamido)ethyl)benzenesulphonyl)-N'-cyclohexylurea N-[2-(4-{[(cyclohexylcarbamoyl)amino]sulfonyl}phenyl)ethyl]-5-methylpyrazine-2-carboxamide N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methylpyrazine-2-carboxamide N-{4-[β-(5-methylpyrazine-2-carboxamido)ethyl]benzenesulphonyl}-N'-cyclohexylurea NCGC00015462-01 NCGC00015462-02 NCGC00015462-05 NCGC00015462-11 NCGC00016802-01 NCGC00023748-03 NCGC00023748-04 NCGC00023748-05 NCGC00023748-06 NCGC00023748-07 Napizide Ozidia Pfizer Brand 1 of Glipizide Pfizer Brand 2 of Glipizide Prestwick0_000131 Prestwick1_000131 Prestwick2_000131 Prestwick3_000131 Prestwick_242 S1715_Selelck S1715_Selleck SAM002564210 SMR000058455 SPBio_002141 STK631952 Samarium(III) ionophore I Semiglynase Sucrazide TK 1320 TL8006447 UNII-X7WDT95N5C ZINC00537795 glipizide nchembio.128-comp32 |
| | 41 | | Saxagliptin | approved | Phase 4, Phase 3, Phase 1 | 127 | 361442-04-8 | 11243969 | (1S,3S,5S)-2-((2S)-Amino(3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrile (1S,5S)-2-[2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile .1.13,7]dec-1-yl)acetyl]-, (1S,3S,5S)- (9CI) 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-amino(3-hydroxytricyclo[3.3 361442-04-8 AC-6008 BMS 477118-11 BMS-477118 | BMS-477118-11 CHEBI:460723 CHEMBL385517 CID11243969 DB06335 OPC-262 Onglyza S1540_Selleck Saxagliptin Saxagliptin anhydrous |
| | 42 | | Eplerenone | approved | Phase 4, Phase 1 | 96 | 107724-20-9 | 150310, 443872 | 107724-20-9 7alpha-methoxycarbonyl-3-oxo-9,11alpha-epoxy-17alpha-pregn-4-ene-21,17-carbolactone AC-4213 AC1L9FDC C12512 CGP-30083 CHEBI:31547 CHEBI:726453 CHEMBL1095097 CID443872 D01115 Eplerenone | Eplerenone (JAN/USAN/INN) Epoxymexrenone Inspra Inspra (TN) Inspra, Epoxymexrenone, CGP30083, SC-66110,Eplerenone MolPort-003-986-216 NCGC00159559-01 NCGC00159559-02 S1707_Selleck SC-66110 Selara TL8000270 ZINC03985982 | |
| | 43 | | Spironolactone | approved | Phase 4, Phase 1 | 232 | 1952-01-7, 52-01-7 | 5833 | 4-18-00-01601 (Beilstein Handbook Reference) 4-Pregnen-21-oic acid-17alpha-ol-3-one-7alpha-thiol gamma-lactone 7-acetate 496916-40-6 52-01-7 7-alpha-Acetylthio-3-oxo-17-alpha-pregn-4-ene-21,17-beta-carbolactone 7alpha-(acetylsulfanyl)-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone AB00513806 AC-4214 AC1L1L8Q Abbolactone Acelat Aldace Aldactazide Aldactide Aldactone Aldactone (TN) Aldactone A Alderon Aldopur Almatol Alphapharm Brand of Spironolactone Alpharma Brand of Spironolactone Alter Brand of Spironolactone Altex Aquareduct Ashbourne Brand of Spironolactone Azupharma Brand of Spironolactone BIDD:PXR0071 BPBio1_000194 BRD-K90027355-001-03-4 BRN 0057767 BSPBio_000176 C07310 C24H32O4S CHEBI:428201 CHEBI:45692 CHEBI:9241 CHEMBL1393 CID5833 CPD000471892 Cardel Brand of Spironolactone D00443 D013148 DB00421 Deverol Dexo Brand of Spironolactone Diatensec Dira Duraspiron EINECS 200-133-6 Espironolactona Espironolactona Alter Espironolactona Mundogen Espironolactona [INN-Spanish] Euteberol Flumach Frumikal Generosan Brand of Spironolactone HMS1568I18 HMS2090N21 HSDB 3184 Hormosan Brand of Spironolactone I06-1970 Jenapharm Brand of Spironolactone Jenaspiron LS-118614 LT00772287 Lacalmin Lacdene Laractone MLS001074672 MLS001333253 MLS001333254 MLS002153245 MLS002207058 Mayoly-Spindler Brand of Spironolactone Melarcon Merck dura Brand of Spironolactone Mundogen Brand of Spironolactone NCGC00164397-01 | NCGC00164397-02 NSC 150399 NSC150399 Nefurofan Novo Spiroton Novo-Spiroton NovoSpiroton Novopharm Brand of Spironolactone Osyrol Pfizer Brand of Spironolactone Pharmafrid Brand of Spironolactone Practon Prestwick0_000128 Prestwick1_000128 Prestwick2_000128 Prestwick3_000128 Roche Brand of Spironolactone S0260 S3378_SIGMA SAM002264648 SC 9420 SC-9420 SC9420 SMR000471892 SNL SPBio_002115 Sagisal Searle Brand of Spironolactone Sincomen Spiractin Spiresis Spiretic Spiridon Spiro L.U.T. Spiro(17H-cyclopenta(a)phenauthrene-17,2'-(3'H)-furan) Spiro-Tablinen Spiro[17H-cyclopenta[a]phenauthrene-17,2'-(3'H)-furan] Spirobeta Spiroctan Spiroctanie Spiroderm Spirogamma Spirolactone Spirolakton Spirolang Spirolone Spirone Spirono Isis Spirono-Isis Spironocompren Spironolactone Spironolactone (JP15/USP/INN) Spironolactone A Spironolactone [BAN:INN:JAN] Spironolactone [INN:BAN:JAN] Spironolactonum Spironolactonum [INN-Latin] Spironolattone Spironolattone [DCIT] Spironone Spirospare Sprioderm Supra-puren Suracton UNII-27O7W4T232 Uractone Urusonin Veroshpiron Verospiron Verospirone Verospirone Opianin WLN: L E5 B666 FX OV MUTJ A1 E1 KSV1 F-& CT5VOXTJ Worwag Brand of Spironolactone Xenalon ZINC03861599 betapharm Brand of Spironolactone ct Arzneimittel Brand of Spironolactone ct-Arzneimittel Brand of Spironolactone spiro von ct spironolactone spironolattone von ct, spiro |
| | 44 | | Liraglutide | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 329 | 204656-20-2 | | 204656-20-2 Arg34Lys26-(N-ε-(γ-Glu(N-α-hexadecanoyl)))-GLP-1[7-37] C439759 Liraglutida Liraglutida [INN-Spanish] Liraglutide Liraglutide [USAN:INN] Liraglutide recombinant Liraglutidum Liraglutidum [INN-Latin] N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)GLP-1-(7-37)-peptide | N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glucagon-like-peptide-1-(7-37)-peptide NN 2211 NN-2211 NN2211 NNC 90-1170 N²⁶-(N-Hexadecanoyl-L-gamma-glutamyl)-[34-L-arginine]glucagon-like peptide 1-(7-37)-peptide N²⁶-(hexadecanoyl-gamma-glutamyle)-[34-arginine]GLP-1-(7-37)-peptide UNII-839I73S42A Victoza nn 2211 nn2211 victoza | |
| | 45 | | Oseltamivir | approved | Phase 4 | 104 | 204255-11-8, 196618-13-0 | 65028 | (-)-oseltamivir (3R,4R,5S)-4-Acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylic acid (−)-oseltamivir 196618-13-0 204255-11-8 4-Acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid AC1L22FK AC1Q63H0 Agucort Agucort (TN) BIDD:GT0426 BRD-K76011241-045-01-5 C08092 CHEBI:7798 CHEMBL1229 CID65028 D08306 DB00198 Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate Ethyl (5S,3R,4R)-4-(acetylamino)-5-amino-3-(ethylpropoxy)cyclohex-1-enecarboxylate FT-0082384 | GS 4104 GS-4104 GS4104 HMS2090C11 HSDB 7433 LS-57422 MolPort-005-933-026 NCGC00178698-01 Oseltamivir Oseltamivir (INN) Oseltamivir [INN:BAN] Oseltamivir phosphate Oseltamivirum Ro-64-0796 Ro-640796 Tamiflu (*Phosphate salt 1:1*) Tamiflu-Free Tamvir UNII-20O93L6F9H ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate oseltamivir oseltamivirum oséltamivir |
| | 46 | | Betamethasone | approved, vet_approved | Phase 4 | 195 | 378-44-9 | 9782 | .beta.-Methasone .beta.-Methasone alcohol 1,4-Pregnadiene-3,20-dione-9alpha-fluoro-16 beta-methyl-11 beta,17alpha,21-triol 16beta-Methyl-1,4-pregnadiene-9alpha-fluoro-11beta,17alpha,21-triol-3,20-dione 16β-Methyl-1,4-pregnadiene-9α-fluoro-11β,17α,21-triol-3,20-dione 24024-03-1 34166_FLUKA 34166_RIEDEL 378-44-9 4-08-00-03501 (Beilstein Handbook Reference) 9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione 9-Fluoro-11-beta,17,21-trihydroxy-16-beta-methylpregna-1,4-diene-3,20-dione 9-Fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 9-Fluoro-16.beta.-methylprednisolone 9-Fluoro-16beta-methylprednisolone 9-Fluoro-16β-methylprednisolone 9-alpha-Fluoro-16-beta-methylprednisolone 9.alpha.-Fluoro-16.beta.-methylprednisolone 9alpha-Fluoro-16 beta-methyl-prednisolone 9alpha-Fluoro-16beta-methylprednisolone 9α-Fluoro-16β-methylprednisolone AC1L1EYE AC1L1TT4 AC1Q5HJZ AKOS001582690 AR-1A7284 AR-1H5595 B1837 B7005_SIAL B7005_SIGMA B9675_SIAL BIDD:PXR0047 BPBio1_000533 BRD-A35108200-001-04-7 BRD-K39188321-001-03-9 BRN 3176546 BSPBio_000483 Bebate Becort Bedifos Betacorlan Betacortril Betadexamethasone Betafluorene Betamamallet Betametasona Betametasona [INN-Spanish] Betametasone Betametasone [DCIT] Betamethasone Betamethasone (JP15/USP/INN) Betamethasone Base Betamethasone Valearate Betamethasone [USAN:BAN:INN:JAN] Betamethasone [USAN:INN:BAN:JAN] Betamethasone alcohol Betamethasone cream Betamethasonum Betamethasonum [INN-Latin] Betamethasonvalerat Mikron Betamethazone Betapredol Betasolon Betnelan | Betsolan C22H29FO5 CHEBI:3077 CHEMBL632 CID3003 CID9782 CPD000339803 Celestene Celeston Celestona Celestone Celestone Syrup and Tablets Celestone, Betadexamethasone, Flubenisolone, Sch-4831, NCS-39470, Betamethasone Cellestoderm Cidoten D00244 D1961 DB00443 Desacort-Beta EINECS 206-825-4 Flubenisolone HMS1569I05 HSDB 3015 Hormezon I06-0121 KST-1A3042 LS-118466 LT00441022 Luxiq Luxiqo MLS-0310139.0001 MLS000686794 MLS000859943 MLS001066413 MLS001332616 MLS002153244 Methazon MolPort-003-845-025 MolPort-007-981-051 NCGC00164401-01 NCGC00164401-02 NSC 39470 NSC-39470 NSC39470 Prestwick0_000362 Prestwick1_000362 Prestwick2_000362 Prestwick3_000362 Prestwick_703 Rinderon Rinderon (TN) Rinderon A S1500_Selleck SAM002589959 SCH 4831 SCH-4831 SMP1_000043 SMR000058601 SMR000339803 SPBio_002404 UNII-9842X06Q6M Valisone Visubeta ZINC03876136 beta-Methasone beta-Methasone alcohol betamethasone |
| | 47 | | Orlistat | approved, investigational | Phase 4, Phase 3, Phase 2 | 52 | 96829-58-2 | 3034010 | (-)-Tetrahydrolipstatin 1-((3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl-2-formamido-4-methylvalerate 111397-16-1 96829-58-2 AC-19012 AC1MHWQP Alli Alli, Xenical, Tetrahydrolipstatin, Orlistat BIDD:GT0853 C055122 C29H53NO5 CHEMBL175247 CID3034010 CPD000466339 D04028 DB01083 FT-0082584 GlaxoSmithKline brand of orlistat HMS2051I08 Hoffmann-La Roche brand of orlistat KS-1183 L-Leucine, N-formyl-, (1S)-1-(((2S,3S)-3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl ester L-Leucine,N-formyl-, (1S)-1-(((2S,3S)-3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl ester LS-178328 MLS000759448 MLS001423955 | MLS002207022 MolPort-005-938-035 N-Formyl-L-leucine (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester N-Formyl-L-leucine, ester with (3S,4S)-3-hexyl-4-((2S)-2-hydroxytridecyl)-2-oxetanone NCGC00165856-01 O4139_SIGMA Orlipastat Orlipastatum Orlipastatum [INN-Latin] Orlistat (USAN/INN) Orlistat [USAN:INN] R-212 Ro 18-0647/002 Ro 18-0647/008 Ro-18-0647 Roche brand of orlistat S1629_Selleck SAM001246637 SMR000466339 THLP Tetrahydrolipstatin UNII-95M8R751W8 Xenical Xenical (TN) [(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate nchembio.129-comp24 orlistat | |
| | 48 | | Tolvaptan | approved | Phase 4, Phase 2, Phase 3 | 90 | 150683-30-0 | 216237 | ( -)-4'-((7-Chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl)carbonyl)-o-tolu-m-toluidide 150683-30-0 7-Chloro-5-hydroxy-1-(2-methyl-4-(2-methylbenzoylamino)benzoyl)2,3,4,5-tetrahydro-1H-1-benzazepine AC1L50C9 C116664 CHEBI:327437 CHEMBL344159 CID216237 | L001628 N-[4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)-3-methylphenyl]-2-methylbenzamide OPC 41061 OPC-41061 PDSP1_001738 PDSP2_001721 Samsca Tolvaptan UNII-21G72T1950 benzazepine derivative, 32 |
| | 49 | | Glyburide | approved | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 114 | 10238-21-8 | 3488 | 1-((p-(2-(5-Chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea 1-((p-(2-(5-chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea 1-(p-(2-(5-Chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea 1-(p-(2-(5-chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea 10238-21-8 5-Chloro-N-[4-(cyclohexylureidosulfonyl)phenethyl]-2-methoxybenzamide 5-chloro-N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide 5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide AB00051949 AC1L1G1Q AC1Q44V7 AKOS001487495 Abbenclamide Adiab Apo-Glibenclamide Azuglucon BIDD:GT0239 BPBio1_000344 BRD-K36927236-001-06-0 BRN 2230085 BSPBio_000312 BSPBio_001351 BSPBio_003053 Bastiverit Benclamin Betanase Betanese 5 Bio-0156 Bio1_000076 Bio1_000565 Bio1_001054 Bio2_000071 Bio2_000551 C07022 C23H28ClN3O5S CAS-10238-21-8 CBiol_001790 CHEBI:5441 CHEMBL472 CID3488 CPD000058229 Calabren Cytagon D00336 D005905 DB01016 Daonil Debtan Dia-basan Diabeta Diabeta (TN) Diabiphage Dibelet DivK1c_000481 Duraglucon EINECS 233-570-6 EU-0100499 Euclamin Euglucan Euglucon Euglucon 5 Euglucon N Euglykon G 0639 G0639_SIAL G0639_SIGMA G2539_SIAL GBN 5 Gen-Glybe Gewaglucon Gilemal Glamide Glibadone Gliban Gliben Gliben-Puren N Glibenbeta Glibenclamid AL Glibenclamid Basics Glibenclamid Fabra Glibenclamid Genericon Glibenclamid Heumann Glibenclamid Riker M Glibenclamid Riker M. Glibenclamid-Cophar Glibenclamid-Ratiopharm Glibenclamida Glibenclamida [INN-Spanish] Glibenclamide Glibenclamide (JP15/INN) Glibenclamidum Glibenclamidum [INN-Latin] Glibenil Glibens Glibesyn Glibet Glibetic Glibil Gliboral Glicem Glidiabet Glimel Glimide Glimidstata Glisulin Glitisol Glubate Gluben Gluco-Tablimen Glucobene Glucohexal Glucolon Glucomid Glucoremed Glucoven Glyben Glybenclamide Glybenzcyclamide Glyburide Glyburide (USP) Glyburide (micronized) Glyburide [USAN] | Glycolande Glycomin Glynase Glynase (TN) HB 419 HB 420 HB-419 HB-420 HB419 HB420 HMS1361D13 HMS1568P14 HMS1791D13 HMS1922L08 HMS1989D13 HMS2089L06 HMS2093P04 HMS501I03 Hemi-Daonil Hexaglucon Humedia I06-0716 IDI1_000481 IDI1_033821 KBio1_000481 KBio2_000071 KBio2_000730 KBio2_002639 KBio2_003298 KBio2_005207 KBio2_005866 KBio3_000141 KBio3_000142 KBio3_002273 KBioGR_000071 KBioGR_001897 KBioSS_000071 KBioSS_000730 LS-159295 Lederglib Libanil Lisaglucon Lopac-G-0639 Lopac0_000499 MLS000069721 MLS001077262 Malix Maninil Med-Glionil Melix Micronase Micronase (TN) Micronized glyburide Miglucan MolPort-000-784-850 N-(4-(2-(5-Chloro-2-methoxybenzamido)ethyl)phenylsulfonyl)-N'-cyclohexylurea N-p-[2-(5-Chloro-2-methoxybenzamido)-ethyl]benzene-sulfonyl-N -cyclohexylurea N-p-[2-(5-Chloro-2-methoxybenzamido)ethyl]benzenesulfonyl-N'-cyclohexylurea NCGC00015467-01 NCGC00015467-02 NCGC00015467-06 NCGC00015467-16 NCGC00016689-01 NCGC00023447-02 NCGC00023447-04 NCGC00023447-05 NCGC00023447-06 NCGC00023447-07 NCGC00023447-08 NCGC00023447-09 NCGC00023447-10 NCGC00023447-11 NCGC00023447-12 NINDS_000481 Nadib Neogluconin Norglicem 5 Normoglucon Novo-Glyburide Oprea1_764617 Orabetic Pira Praeciglucon PresTab Prestwick0_000316 Prestwick1_000316 Prestwick2_000316 Prestwick3_000316 Prestwick_569 Probes1_000431 Probes2_000378 Prodiabet Renabetic S1716_Selleck SAM002564212 SMR000058229 SPBio_001831 SPBio_002531 SPECTRUM2300229 SR-01000000196-5 STK362992 Semi-Daonil Semi-Euglucon Semi-Gliben-Puren N Semi-daonil Spectrum2_001816 Spectrum3_001327 Spectrum4_001199 Spectrum5_001631 Spectrum_000250 Sugril Suraben Tiabet Tocris-0911 U 26452 U-26452 UNII-SX6K58TVWC UPCMLD-DP006 UPCMLD-DP006:001 UR 606 Yuglucon ZINC00537805 glibenclamide glyburide |
| | 50 | | Alogliptin | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 60 | 850649-61-5 | 11450633 | 2-({6-[(3r)-3-Aminopiperidin-1-Yl]-3-Methyl-2,4-Dioxo-3,4-Dihydropyrimidin-1(2h)-Yl}methyl)benzonitrile 850649-61-5 Alogliptin Alogliptina Alogliptine | Alogliptinum CHEMBL376359 CID11450633 MolPort-005-933-065 SYR-322 UNII-JHC049LO86 | |
|
Interventional clinical trials: (show top 50)
(show all 5004)
| id | Name | Status | NCT ID | Phase |
|---|
| 1 | Characterisation of the Human Carboxylesterase 1 (CES1) Mutations in Thailand | Unknown status | NCT01443806 | Phase 4 | | 2 | Mixed Meal Test in Type 1 Diabetes: Optimization of Artificial Pancreas-Pilot Study | Unknown status | NCT01800734 | Phase 4 | | 3 | Mixed Meal Test in Type 1 Diabetes on Insulin Pump Therapy: Optimization of Artificial Pancreas | Unknown status | NCT02003274 | Phase 4 | | 4 | Efficacy of Acarbose on Intestinal Microbiome and Incretins of Type 2 Diabetes | Unknown status | NCT01758471 | Phase 4 | | 5 | Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparing Regimen in HIV Infected Patients | Unknown status | NCT00135460 | Phase 4 | | 6 | Trial of Supplementation With Aged Garlic Extract to Improve Endothelial Function in Patients With Metabolic Syndrome | Unknown status | NCT01168700 | Phase 4 | | 7 | Intensive Versus Nonintensive Insulin Therapy for Hyperglycemia After Traumatic Brain Injury | Unknown status | NCT02161055 | Phase 4 | | 8 | The Effect of Early Total Thyroidectomy in the Course of Graves' Orbitopathy | Unknown status | NCT01056419 | Phase 4 | | 9 | A Prospective, Randomized Trial of Intravenous Pulse Versus Sequential Steroid Therapy for Patients With Graves' Orbitopathy | Unknown status | NCT01969019 | Phase 4 | | 10 | How Bone is Made in Children Receiving Dialysis | Unknown status | NCT01799317 | Phase 4 | | 11 | Alendronate for Vascular Calcification in Peritoneal Dialysis Patients? | Unknown status | NCT00299572 | Phase 4 | | 12 | Efficacy and Safety Study of 5 mg and 10 mg Rosuvastatin | Unknown status | NCT01613729 | Phase 4 | | 13 | An Open-Label Extension to Assess the Continued Efficacy of Omacor Plus Simvastatin | Unknown status | NCT00678743 | Phase 4 | | 14 | Lactate and Hypoglycemia | Unknown status | NCT01387477 | Phase 4 | | 15 | Vitamin D and Glucose Metabolism in Pediatrics | Unknown status | NCT01386736 | Phase 4 | | 16 | Prevalence of Macrovascular Disease in Type 2 Diabetes Mellitus | Unknown status | NCT00298844 | Phase 4 | | 17 | Korean AMADEUS Study | Unknown status | NCT01239849 | Phase 4 | | 18 | Multifactorial Intervention in Type 2 Diabetes - Italy | Unknown status | NCT01240070 | Phase 4 | | 19 | Insulin Effects on Metabolism and Cardiovascular Function in Type 2 Diabetes | Unknown status | NCT00747409 | Phase 4 | | 20 | Effect of Adding Vildagliptin on Beta Cell Function and Cardiovascular Risk Markers in Patients With Moderate Metabolic Control During Metformin Monotherapy | Unknown status | NCT01565096 | Phase 4 | | 21 | Effect of Linagliptin in Comparison With Glimepiride as Add on to Metformin on Postprandial Beta Cell Function, Postprandial Metabolism and Oxidative Stress in Patients With Type 2 Diabetes Mellitus | Unknown status | NCT01547104 | Phase 4 | | 22 | Efficacy and Safety of Lobeglitazone Versus Sitagliptin | Unknown status | NCT02480465 | Phase 4 | | 23 | Triple Therapy in Type 2 Diabetic Patients | Unknown status | NCT01895569 | Phase 4 | | 24 | Cilostazol Versus Aspirin for Primary Prevention of Atherosclerotic Events | Unknown status | NCT00886574 | Phase 4 | | 25 | Examining Genetic Influence on Response to Beta-Blocker Medications in People With Type 2 Diabetes | Unknown status | NCT00925119 | Phase 4 | | 26 | Glucagon Like Peptides Receptors Expression in the Stomach of Diabetes Type 2 | Unknown status | NCT00473733 | Phase 4 | | 27 | Continuous Glucose Monitoring in Patients With Type 2 Diabetes | Unknown status | NCT00529815 | Phase 4 | | 28 | Oxidative Stress Lowering Effect of Simvastatin and Atorvastatin. | Unknown status | NCT00404599 | Phase 4 | | 29 | Vascular Effects of Sitagliptin in Diabetes Mellitus | Unknown status | NCT01096277 | Phase 4 | | 30 | Multiple Grain in Type 2 Diabetes | Unknown status | NCT00337337 | Phase 4 | | 31 | Outpatient Discharge Therapy With Saxagliptin+MetforminXR vs GlipizideXL for Type 2 Diabetes With Severe Hyperglycemia | Unknown status | NCT01267448 | Phase 4 | | 32 | Organization Program of DiabEtes INsulIN ManaGement | Unknown status | NCT01338376 | Phase 4 | | 33 | Metformin and Sitagliptin Therapy for Adult Patients With Type 2 Diabetes Admitted to the General Medical Unit | Unknown status | NCT02250794 | Phase 4 | | 34 | Effects of Vildagliptin Versus Glibenclamide on Glycemia After Exercise in Patients With Type 2 Diabetes | Unknown status | NCT01867502 | Phase 4 | | 35 | Bone Turnover in Type 2 Diabetes Patients | Unknown status | NCT00732121 | Phase 4 | | 36 | The Efficacy of Glucerna SR in Chinese Drug-naïve Subjects With Type 2 Diabetes | Unknown status | NCT02248714 | Phase 4 | | 37 | Comparison of Pioglitazone Versus Glimepiride in Type 2 Diabetes Inadequately Controlled With Metformin Plus Alogliptin | Unknown status | NCT02426294 | Phase 4 | | 38 | Mechanistic Study of the Systolic Blood Pressure Lowering Effect of Dapagliflozin in Type 2 Diabetes | Unknown status | NCT02372955 | Phase 4 | | 39 | Clinical Study to Compare Various Dosing and Titration Guidelines of Insulin Delivered Via V-Go ® in Patients With Type 2 Diabetes Initiating Basal Bolus Therapy in Primary Care Offices | Unknown status | NCT02361489 | Phase 4 | | 40 | The Effect of Combination of Mosapride and DPP-4 Inhibitor on Plasma Concentration of Incretin Hormones | Unknown status | NCT02180334 | Phase 4 | | 41 | TReatment by Insulin Continuous Infusion in Type 2 DIAbetes | Unknown status | NCT01889914 | Phase 4 | | 42 | Effect of Liraglutide Combined With Short-term CSII on Long-term Glycemic Remission and β Cell Function | Unknown status | NCT01790308 | Phase 4 | | 43 | Combinatorial Therapy for Peristent Type 2 Diabetes After Gastric Banding | Unknown status | NCT01597531 | Phase 4 | | 44 | The Titan Versus Everolimus Intracoronary Stent (Xience V) in Diabetic Patients | Unknown status | NCT01510509 | Phase 4 | | 45 | Establishing Cardiovascular Biomarkers to Define Preferred Lantus® Use | Unknown status | NCT01500850 | Phase 4 | | 46 | Study of Comparison the Treatment Effect Between Gastric Bypass and Exenatide in Type 2 Diabetes | Unknown status | NCT01435980 | Phase 4 | | 47 | Human Insulin Analogs: Evaluation of Inflammatory mRNA Expression of Macrophages and Endothelial Function of Short-acting Insulin - HERMES Pilot Study | Unknown status | NCT01417897 | Phase 4 | | 48 | German Diabetes-Diet-Intervention and Energy Restriction-Trial (DDIET) | Unknown status | NCT01409330 | Phase 4 | | 49 | Compare the Effect of DPP-IV Inhibitor or TZD on Glycemic Variability and Oxidative Stress in Patient With 2 Diabetes | Unknown status | NCT01339143 | Phase 4 | | 50 | Investigation of a Switch From Insulin Therapy to a Metformin & Saxagliptin Combination in Patients With Type 2 Diabetes Mellitus | Unknown status | NCT01206647 | Phase 4 |
Inferred drug relations via UMLS68/NDF-RT46:
|
